FALSE --12-31 1 1 FY 0001009001 2022 1 1 P1Y P3Y P1Y P1Y no
1
EXHIBIT 99.2
Cameco Corporation
2022 Consolidated Audited Financial Statements
February 8, 2023
2
Cameco Corporation
2022 consolidated financial statements
February 8, 2023
3
Report of management’s accountability
The accompanying consolidated financial statements have been prepared by management in accordance with International
Financial Reporting Standards as issued by the International Accounting Standards Board. Management is responsible for
ensuring that these statements, which include amounts based upon estimates and judgments, are consistent with other
information and operating data contained in the annual financial review and reflect the corporation's business transactions and
financial position.
Management is also responsible for the information disclosed in the management’s discussion and analysis including
responsibility for the existence of appropriate information systems, procedures and controls to ensure that the information
used internally by management and disclosed externally is complete and reliable in all material respects.
In addition, management is responsible for establishing and maintaining an adequate system of internal control over financial
reporting. The internal control system includes an internal audit function and a code of conduct and ethics, which is
communicated to all levels in the organization and requires all employees to maintain high standards in their conduct of the
Company's affairs. Such systems are designed to provide reasonable assurance that the financial information is relevant,
reliable and accurate and that the Company’s assets are appropriately accounted for and adequately safeguarded.
Management conducted an evaluation of the effectiveness of the system of internal control over financial reporting based on
the criteria established in “Internal Control – Integrated Framework (2013)” issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on this evaluation, management concluded that the Company’s system of
internal control over financial reporting was effective as of December 31, 2022.
KPMG LLP has audited the consolidated financial statements in accordance with the standards of the Public Company
Accounting Oversight Board (United States).
The board of directors annually appoints an audit and finance committee comprised of directors who are not employees of the
corporation. This committee meets regularly with management, the internal auditor and the shareholders' auditors to review
significant accounting, reporting and internal control matters. Both the internal and shareholders' auditors have unrestricted
access to the audit and finance committee. The audit and finance committee reviews the consolidated financial statements,
the report of the shareholders' auditors, and management’s discussion and analysis and submits its report to the board of
directors for formal approval.
Original signed by Tim S. Gitzel
Original signed by Grant E. Isaac
President and Chief Executive Officer
Senior Vice-President and Chief Financial Officer
February 8, 2023
February 8, 2023
4
Report of independent registered public accounting firm
To
the Shareholders and Board of Directors of Cameco Corporation
Opinion on the consolidated financial statements
We have audited the accompanying consolidated statements of financial position of Cameco Corporation (the “Company”) as
of December 31, 2022 and 2021, the related consolidated statements of earnings, comprehensive income, changes in equity
and cash flows for each of the years in the two-year period ended December 31, 2022, and the related notes (collectively, the
“consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material
respects, the financial position of the Company as of December 31, 2022 and 2021, and its financial performance and its cash
flows for each of the years in the two-year period ended December 31, 2022, in conformity with International Financial
Reporting Standards as issued by the International Accounting Standards Board.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(“PCAOB”), the Company’s internal control over financial reporting as of December 31, 2022,
based on criteria established in
Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO), and our report dated February 8, 2023 expressed an unqualified opinion on the effectiveness of the
Company’s internal control over financial reporting.
Basis for opinion
These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express
an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the
PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws
and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material
misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material
misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that
our audits provide a reasonable basis for our opinion.
Critical audit matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial
statements that was communicated or required to be communicated to the audit and finance committee and that: (1) relates to
accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging,
subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the
consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below,
providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Assessment of recoverability of deferred tax assets
As discussed in note 22 to the consolidated financial statements, as of December 31, 2022 the Company has recorded a
deferred tax asset of $984,071,000. The realization of this deferred tax asset is dependent on the generation of future taxable
income in certain jurisdictions during the periods in which the Company’s deferred tax assets are available. Based on
projections of future taxable income over the periods in which the deferred tax assets are available, realization of these
deferred tax assets is probable. As discussed in note 5D, the calculation of income taxes requires the use of judgment and
estimates. The determination of the recoverability of deferred tax assets is dependent on assumptions and judgments
regarding future market conditions and production rates, which can materially impact estimated future taxable income.
5
We identified the assessment of the recoverability of the deferred tax asset as a critical audit matter due to the high degree of
judgment required in assessing the significant assumptions and judgments that are reflected in the projections of future
taxable income.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and
tested the operating effectiveness of certain internal controls related to the Company’s assessment of the recoverability of the
deferred tax asset, including controls related to the assumptions and judgments used in the projections of future taxable
income. To
assess the Company’s ability to estimate future taxable income, we compared the Company’s previous forecasts
to actual results. To
assess the Company’s estimate of future taxable income, we evaluated certain significant assumptions in
the projections. We compared future market conditions of forecast uranium sales prices to published views of independent
market participants. We compared forecast sales to historical trends, board approved budgets and committed sales volumes,
including to a selection of committed sales contracts. We compared forecast production rates to historical data, board
approved budgets and life of mine plans. We involved income tax professionals with specialized skills and knowledge to assist
in assessing the Company’s application of the tax regulations in relevant jurisdictions.
Original signed by KPMG LLP
Chartered Professional Accountants
We have served as the Company’s auditor since 1988.
Saskatoon, Canada
February 8, 2023
6
Report of independent registered public accounting firm
To
the Shareholders and Board of Directors of Cameco Corporation
Opinion on internal control over financial reporting
We have audited Cameco Corporation’s (the “Company”) internal control over financial reporting as of December 31, 2022,
based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring
Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective
internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control – Integrated
Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(“PCAOB”), the consolidated statements of financial position of the Company as of December 31, 2022 and 2021, the related
consolidated statements of earnings, comprehensive income, changes in equity and cash flows for each of the years in the
two-year period ended December 31, 2022, and the related notes (collectively, the "consolidated financial statements") and
our report dated February 8, 2023 expressed an unqualified opinion on those consolidated financial statements.
Basis for opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of
management’s accountability. Our responsibility is to express an opinion on the Company’s internal control over financial
reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent
with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the
Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all
material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control
over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and
operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our
opinion.
Definition and limitations of internal control over financial reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to
permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the company are being made only in accordance with authorizations of management and directors of the
company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or
disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
7
Original signed by KPMG LLP
Chartered Professional Accountants
Saskatoon, Canada
February 8, 2023
8
Consolidated statements of earnings
For the years ended December 31
Note
2022
2021
($Cdn thousands, except per share amounts)
Revenue from products and services
18
$
1,868,003
$
1,474,984
Cost of products and services sold
1,457,336
1,282,635
Depreciation and amortization
177,376
190,415
Cost of sales
29
1,634,712
1,473,050
Gross profit
233,291
1,934
Administration
172,029
127,566
Exploration
10,578
8,016
Research and development
12,175
7,168
Other operating expense (income)
16
22,944
(8,407)
Loss on disposal of assets
514
3,803
Earnings (loss) from operations
15,051
(136,212)
Finance costs
20
(85,728)
(76,612)
Gain (loss) on derivatives
27
(72,949)
12,529
Finance income
37,499
6,804
Share of earnings from equity-accounted investee
12
93,988
68,283
Other income
21
96,934
21,353
Earnings (loss) before income taxes
84,795
(103,855)
Income tax recovery
22
(4,469)
(1,201)
Net earnings (loss)
$
89,264
$
(102,654)
Net earnings (loss) attributable to:
Equity holders
89,382
(102,577)
Non-controlling interest
(118)
(77)
Net earnings (loss)
$
89,264
$
(102,654)
Earnings (loss) per common share attributable to equity holders:
Basic
23
$
0.22
$
(0.26)
Diluted
23
$
0.22
$
(0.26)
See accompanying notes to consolidated financial statements.
9
Consolidated statements of comprehensive income
For the years ended December 31
Note
2022
2021
($Cdn thousands)
Net earnings (loss)
$
89,264
$
(102,654)
Other comprehensive income (loss), net of taxes:
-
-
Items that will not be reclassified to net earnings:
Remeasurements of defined benefit liability
1
26
19,242
3,897
Equity investments at FVOCI - net change in fair value
2
-
22,059
-
Items that are or may be reclassified to net earnings:
Exchange differences on translation of foreign operations
(38,141)
(30,384)
Other comprehensive loss, net of taxes
(18,899)
(4,428)
Total comprehensive income (loss)
$
70,365
$
(107,082)
Other comprehensive income (loss) attributable to:
Equity holders
$
(18,901)
$
(4,426)
Non-controlling interest
2
(2)
Other comprehensive loss for the year
$
(18,899)
$
(4,428)
Total comprehensive income (loss) attributable to:
Equity holders
$
70,481
$
(107,003)
Non-controlling interest
(116)
(79)
Total comprehensive income (loss) for the year
$
70,365
$
(107,082)
1
Net of tax (2022 - $(
5,440
); 2021 - $(
1,274
))
2
Net of tax (2022 - $
0
; 2021 - $(
3,267
))
See accompanying notes to consolidated financial statements.
10
Consolidated statements of financial position
As at December 31
Note
2022
2021
($Cdn thousands)
Assets
Current assets
Cash and cash equivalents
$
1,143,674
$
1,247,447
Short-term investments
1,138,174
84,906
Accounts receivable
7
183,944
276,139
Current tax assets
1,056
4,966
Inventories
8
664,698
409,521
Supplies and prepaid expenses
157,910
95,341
Current portion of long-term receivables, investments and other
11
32,180
23,232
Total
current assets
3,321,636
2,141,552
Property, plant and equipment
9
3,473,490
3,576,599
Intangible assets
10
47,117
51,247
Long-term receivables, investments and other
11
595,507
577,527
Investment in equity-accounted investee
12
210,972
233,240
Deferred tax assets
22
984,071
937,579
Total
non-current assets
5,311,157
5,376,192
Total assets
$
8,632,793
$
7,517,744
Liabilities and shareholders' equity
Current liabilities
Accounts payable and accrued liabilities
13
$
374,714
$
340,458
Current tax liabilities
6,498
4,129
Current portion of other liabilities
15
131,324
22,791
Current portion of provisions
16
48,305
46,365
Total
current liabilities
560,841
413,743
Long-term debt
14
997,000
996,250
Other liabilities
15
216,162
171,774
Provisions
16
1,022,725
1,090,009
Total
non-current liabilities
2,235,887
2,258,033
Shareholders' equity
Share capital
2,880,336
1,903,357
Contributed surplus
224,687
230,039
Retained earnings
2,696,379
2,639,650
Other components of equity
34,652
72,795
Total shareholders' equity attributable to equity holders
5,836,054
4,845,841
Non-controlling interest
11
127
Total shareholders' equity
5,836,065
4,845,968
Total liabilities and shareholders' equity
$
8,632,793
$
7,517,744
Commitments and contingencies [notes 9, 16, 22, 33]
See accompanying notes to consolidated financial statements.
11
Consolidated statements of changes in equity
Attributable to equity holders
Foreign
Equity
Non-
Share
Contributed
Retained
currency
investments
controlling
Total
($Cdn thousands)
capital
surplus
earnings
translation
at FVOCI
Total
interest
equity
Balance at January 1, 2022
$
1,903,357
$
230,039
$
2,639,650
$
73,543
$
(748)
$
4,845,841
$
127
$
4,845,968
Net earnings (loss)
-
-
89,382
-
-
89,382
(118)
89,264
Other comprehensive
income (loss)
-
-
19,242
(38,143)
-
(18,901)
2
(18,899)
Total comprehensive
income (loss)
-
-
108,624
(38,143)
-
70,481
(116)
70,365
Share-based compensation
-
3,318
-
-
-
3,318
-
3,318
Stock options exercised
12,101
(2,469)
-
-
-
9,632
-
9,632
Restricted share units
released
-
(6,201)
-
-
-
(6,201)
-
(6,201)
Dividends
-
-
(51,895)
-
-
(51,895)
-
(51,895)
Equity issuance [note 17]
964,878
-
-
-
-
964,878
-
964,878
Balance at December 31, 2022
$
2,880,336
$
224,687
$
2,696,379
$
35,400
$
(748)
$
5,836,054
$
11
$
5,836,065
Balance at January 1, 2021
$
1,869,710
$
237,358
$
2,735,830
$
103,925
$
11,532
$
4,958,355
$
206
$
4,958,561
Net loss
-
-
(102,577)
-
-
(102,577)
(77)
(102,654)
Other comprehensive
income (loss)
-
-
3,897
(30,382)
22,059
(4,426)
(2)
(4,428)
Total comprehensive
income (loss)
-
-
(98,680)
(30,382)
22,059
(107,003)
(79)
(107,082)
Share-based compensation
-
4,536
-
-
-
4,536
-
4,536
Stock options exercised
33,647
(6,876)
-
-
-
26,771
-
26,771
Restricted share units
released
-
(4,979)
-
-
-
(4,979)
-
(4,979)
Dividends
-
-
(31,839)
-
-
(31,839)
-
(31,839)
Transfer to retained
earnings [note 27]
-
-
34,339
-
(34,339)
-
-
-
Balance at December 31, 2021
$
1,903,357
$
230,039
$
2,639,650
$
73,543
$
(748)
$
4,845,841
$
127
$
4,845,968
See accompanying notes to consolidated financial statements.
12
Consolidated statements of cash flows
For the years ended December 31
Note
2022
2021
($Cdn thousands)
Operating activities
Net earnings (loss)
$
89,264
$
(102,654)
Adjustments for:
Depreciation and amortization
177,376
190,415
Deferred sales
43,528
608
Unrealized loss on derivatives
82,636
13,771
Share-based compensation
25
3,318
4,536
Loss on disposal of assets
514
3,803
Finance costs
20
85,728
76,612
Finance income
(37,499)
(6,804)
Share of earnings from equity-accounted investee
12
(93,988)
(68,283)
Other income
21
(96,934)
(446)
Other operating expense (income)
16
22,944
(8,407)
Income tax recovery
22
(4,469)
(1,201)
Interest received
35,443
9,374
Income taxes received (paid)
(1,521)
9,583
Dividends from equity-accounted investee
32
117,698
50,128
Other operating items
24
(119,431)
287,253
Net cash provided by operations
304,607
458,288
Investing activities
Additions to property, plant and equipment
9
(143,448)
(98,784)
Acquisition
6
(101,681)
-
Increase in short-term investments
(1,044,473)
(59,921)
Decrease (increase) in long-term receivables, investments and other
(2,000)
73,050
Proceeds from sale of property, plant and equipment
780
5,357
Net cash used in investing
(1,290,822)
(80,298)
Financing activities
Interest paid
(38,856)
(38,977)
Proceeds from issuance of shares, stock option plan
9,632
26,771
Proceeds from issuance of shares, net of issue costs
17
953,285
-
Lease principal payments
(2,908)
(2,727)
Dividends paid
(51,895)
(31,839)
Net cash provided by (used in) financing
869,258
(46,772)
Increase (decrease) in cash and cash equivalents, during the year
(116,957)
331,218
Exchange rate changes on foreign currency cash balances
13,184
(2,153)
Cash and cash equivalents, beginning of year
1,247,447
918,382
Cash and cash equivalents, end of year
$
1,143,674
$
1,247,447
Cash and cash equivalents is comprised of:
Cash
$
701,818
$
604,557
Cash equivalents
441,856
642,890
Cash and cash equivalents
$
1,143,674
$
1,247,447
See accompanying notes to consolidated financial statements.
13
Notes to consolidated financial statements
For the years ended December 31, 2022 and 2021
1.
Cameco Corporation
Cameco Corporation is incorporated under the Canada Business Corporations Act. The address of its registered office is 2121
11th Street West, Saskatoon, Saskatchewan, S7M 1J3. The consolidated financial statements as at and for the year ended
December 31, 2022 comprise Cameco Corporation and its subsidiaries (collectively, the Company or Cameco) and the
Company’s interests in associates and joint arrangements.
Cameco is one of the world’s largest providers of the uranium needed to generate clean, reliable baseload electricity around
the globe. The Company has mines in northern Saskatchewan and the United States, as well as a 40% interest in Joint
Venture Inkai LLP (JV Inkai), a joint arrangement with Joint Stock Company National Atomic Company Kazatomprom
(Kazatomprom),
located in Kazakhstan. JV Inkai is accounted for on an equity basis (see note 12).
Cameco’s Cigar Lake mine in northern Saskatchewan had been placed in a temporary state of care and maintenance
periodically throughout 2020 and 2021 due to the global COVID-19 pandemic. The mine was in a temporary state of care and
maintenance in January 2021 and production resumed in April 2021. Operations at McArthur River/Key Lake, which had been
suspended in 2018, resumed in November of 2022.
The Rabbit Lake operation was placed in care and maintenance in 2016.
Cameco’s operations in the United States, Crow Butte and Smith Ranch-Highland, are not currently producing as the decision
was made in 2016 to curtail production and defer all wellfield development. See note 29 for the financial statement impact.
The Company is also a leading provider of nuclear fuel processing services, supplying much of the world’s reactor fleet with
the fuel to generate one of the cleanest sources of electricity available today. It operates the world’s largest commercial
refinery in Blind River, Ontario, controls a significant portion of the world UF
6
primary conversion capacity in Port Hope,
Ontario and is a leading manufacturer of fuel assemblies and reactor components for CANDU reactors at facilities in Port
Hope and Cobourg, Ontario.
2.
Significant accounting policies
A.
Statement of compliance
These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards
(IFRS) as issued by the International Accounting Standards Board (IASB).
These consolidated financial statements were authorized for issuance by the Company’s board of directors on February 8,
2023.
B.
Basis of presentation
These consolidated financial statements are presented in Canadian dollars, which is the Company’s functional currency. All
financial information is presented in Canadian dollars, unless otherwise noted. Amounts presented in tabular format have been
rounded to the nearest thousand except per share amounts and where otherwise noted.
The consolidated financial statements have been prepared on the historical cost basis except for the following material items
which are measured on an alternative basis at each reporting date:
14
Derivative financial instruments
Fair value through profit or loss (FVTPL)
Equity investments
Fair value through other comprehensive income
(FVOCI)
Liabilities for cash-settled share-based payment arrangements
FVTPL
Net defined benefit liability
Fair value of plan assets less the present value of the
defined benefit obligation
The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments,
estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities,
revenue and expenses. Actual results may vary from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in
the period in which the estimates are revised and in any future periods affected. The areas involving a higher degree of
judgment or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are
disclosed in note 5.
This summary of significant accounting policies is a description of the accounting methods and practices that have been used
in the preparation of these consolidated financial statements and is presented to assist the reader in interpreting the
statements contained herein. These accounting policies have been applied consistently to all entities within the consolidated
group.
C.
Consolidation principles
i.
Business combinations
The acquisition method of accounting is used to account for the acquisition of subsidiaries by the Company. The Company
measures goodwill at the acquisition date as the fair value of the consideration transferred, including the recognized amount of
any non-controlling interests in the acquiree, less the net recognized amount (generally fair value) of the identifiable assets
acquired and liabilities assumed, all measured as of the acquisition date. When the excess is negative, a bargain purchase
gain is recognized immediately in earnings. In a business combination achieved in stages, the acquisition date fair value of the
Company’s previously held equity interest in the acquiree is also considered in computing goodwill.
Consideration transferred includes the fair values of the assets transferred, liabilities incurred and equity interests issued by
the Company. Consideration also includes the fair value of any contingent consideration and share-based compensation
awards that are replaced mandatorily in a business combination.
The Company elects on a transaction-by-transaction basis whether to measure any non-controlling interest at fair value, or at
their proportionate share of the recognized amount of the identifiable net assets of the acquiree, at the acquisition date.
Acquisition-related costs are expensed as incurred, except for those costs related to the issue of debt or equity instruments.
ii.
Subsidiaries
The consolidated financial statements include the accounts of Cameco and its subsidiaries. Subsidiaries are entities over
which the Company has control. Subsidiaries are fully consolidated from the date on which control is acquired by the Company
and are deconsolidated from the date that control ceases.
iii.
Investments in equity-accounted investees
Cameco’s investments in equity-accounted investees include investments in associates.
Associates are those entities over which the Company has significant influence, but not control or joint control, over the
financial and operating policies. Significant influence is presumed to exist when the Company holds between 20% and 50% of
the voting power of another entity, but can also arise where the Company holds less than 20% if it has the power to be actively
involved and influential in policy decisions affecting the entity.
15
Investments in associates are accounted for using the equity method. The equity method involves the recording of the initial
investment at cost and the subsequent adjusting of the carrying value of the investment for Cameco’s proportionate share of
the earnings or loss and any other changes in the associates’ net assets, such as dividends. The cost of the investment
includes transaction costs.
Adjustments are made to align the accounting policies of the associate with those of the Company before applying the equity
method. When the Company’s share of losses exceeds its interest in an equity-accounted investee, the carrying amount of
that interest is reduced to zero, and the recognition of further losses is discontinued except to the extent that the Company has
incurred legal or constructive obligations or made payments on behalf of the associate. If the associate subsequently reports
profits, Cameco resumes recognizing its share of those profits only after its share of the profits equals the share of losses not
recognized.
iv.
Joint arrangements
A joint arrangement can take the form of a joint operation or joint venture. All joint arrangements involve a contractual
arrangement that establishes joint control.
A joint operation is a joint arrangement whereby the parties that have joint control of the arrangement have rights to the
assets, and obligations for the liabilities, relating to the arrangement. A joint operation may or may not be structured through a
separate vehicle. These arrangements involve joint control of one or more of the assets acquired or contributed for the
purpose of the joint operation. The consolidated financial statements of the Company include its share of the assets in such
joint operations, together with its share of the liabilities, revenues and expenses arising jointly or otherwise from those
operations. All such amounts are measured in accordance with the terms of each arrangement.
A joint venture is a joint arrangement whereby the parties that have joint control of the arrangement have rights to the net
assets of the arrangement. A joint venture is always structured through a separate vehicle. It operates in the same way as
other entities, controlling the assets of the joint venture, earning its own revenue and incurring its own liabilities and expenses.
Interests in joint ventures are accounted for using the equity method of accounting, whereby the Company’s proportionate
interest in the assets, liabilities, revenues and expenses of jointly controlled entities are recognized on a single line in the
consolidated statements of financial position and consolidated statements of earnings. The share of joint ventures results is
recognized in the Company’s consolidated financial statements from the date that joint control commences until the date at
which it ceases.
When acquiring an additional interest in a joint arrangement, previously held interests are not remeasured at fair value. In an
acquisition of an asset or group of assets that does not constitute a business, the directly attributable transaction costs are
included in the cost of the asset or group of assets.
v.
Transactions eliminated on consolidation
Intra-group balances and transactions, and any unrealized income and expenses arising from intra-group transactions, are
eliminated in preparing the consolidated financial statements. Unrealized gains arising from transactions with equity-accounted
investees are eliminated against the investment to the extent of the Company’s interest in the investee. Unrealized losses are
eliminated in the same manner as unrealized gains, but only to the extent that there is no evidence of impairment.
D.
Foreign currency translation
Items included in the financial statements of each of Cameco’s subsidiaries, associates and joint arrangements are measured
using their functional currency, which is the currency of the primary economic environment in which the entity operates. The
consolidated financial statements are presented in Canadian dollars, which is Cameco’s functional and presentation currency.
16
i.
Foreign currency transactions
Foreign currency transactions are translated into the respective functional currency of the Company and its entities using the
exchange rates prevailing at the dates of the transactions. At the reporting date, monetary assets and liabilities denominated in
foreign currencies are translated to the functional currency at the exchange rate at that date. Non-monetary items that are
measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction.
The applicable exchange gains and losses arising on these transactions are reflected in earnings with the exception of foreign
exchange gains or losses on provisions for decommissioning and reclamation activities that are in a foreign currency, which
are capitalized in property, plant and equipment.
ii.
Foreign operations
The assets and liabilities of foreign operations, including goodwill and fair value adjustments arising on acquisition, are
translated to Canadian dollars at exchange rates at the reporting dates. The revenues and expenses of foreign operations are
translated to Canadian dollars at exchange rates at the dates of the transactions.
Foreign currency differences are recognized in other comprehensive income. When a foreign operation is disposed of, in
whole, the relevant amount in the foreign currency translation account is transferred to earnings as part of the gain or loss on
disposal.
When the settlement of a monetary item receivable from or payable to a foreign operation is neither planned nor likely in the
foreseeable future, foreign exchange gains and losses arising from such a monetary item are considered to form part of the
net investment in a foreign operation, and are recognized in other comprehensive income and presented within equity in the
foreign currency translation account.
E.
Cash and cash equivalents
Cash and cash equivalents consists of balances with financial institutions and investments in money market instruments,
which have a term to maturity of three months or less at the time of purchase and are measured at amortized cost.
F.
Short-term investments
Short-term investments are comprised of money market instruments with terms to maturity between three and 12 months and
are measured at amortized cost.
G.
Inventories
Inventories of broken ore, uranium concentrates, and refined and converted products are measured at the lower of cost and
net realizable value.
Cost includes direct materials, direct labour, operational overhead expenses and depreciation. Net realizable value is the
estimated selling price in the ordinary course of business, less the estimated costs of completion and selling expenses.
Consumable supplies and spares are valued at the lower of cost or replacement value.
H.
Property, plant and equipment
i.
Buildings, plant and equipment and other
Items of property, plant and equipment are measured at cost less accumulated depreciation and impairment charges. The cost
of self-constructed assets includes the cost of materials and direct labour, borrowing costs and any other costs directly
attributable to bringing the assets to the location and condition necessary for them to be capable of operating in the manner
intended by management, including the initial estimate of the cost of dismantling and removing the items and restoring the site
on which they are located.
When components of an item of property, plant and equipment have different useful lives, they are accounted for as separate
items of property, plant and equipment and depreciated separately.
17
Gains and losses on disposal of an item of property, plant and equipment are determined by comparing the proceeds from
disposal with the carrying amount of property, plant and equipment, and are recognized in earnings.
ii.
Mineral properties and mine development costs
The decision to develop a mine property within a project area is based on an assessment of the commercial viability of the
property, the availability of financing and the existence of markets for the product. Once the decision to proceed to
development is made, development and other expenditures relating to the project area are deferred as part of assets under
construction and disclosed as a component of property, plant and equipment with the intention that these will be depreciated
by charges against earnings from future mining operations. No depreciation is charged against the property until the
production stage commences. After a mine property has been brought into the production stage, costs of any additional work
on that property are expensed as incurred, except for large development programs, which will be deferred and depreciated
over the remaining life of the related assets.
The production stage is reached when a mine property is in the condition necessary for it to be capable of operating in the
manner intended by management. The criteria used to assess the start date of the production stage are determined based on
the nature of each mine construction project, including the complexity of a mine site. A range of factors is considered when
determining whether the production stage has been reached, which includes, but is not limited to, the demonstration of
sustainable production at or near the level intended (such as the demonstration of continuous throughput levels at or above a
target percentage of the design capacity).
iii.
Depreciation
Depreciation is calculated over the depreciable amount, which is the cost of the asset less its residual value. Assets which are
unrelated to production are depreciated according to the straight-line method based on estimated useful lives as follows:
Land
Not depreciated
Buildings
15
-
25
years
Plant and equipment
3
-
15
years
Furniture and fixtures
3
-
10
years
Other
3
-
5
years
Mining properties and certain mining and conversion assets for which the economic benefits from the asset are consumed in a
pattern which is linked to the production level are depreciated according to the unit-of-production method. For conversion
assets, the amount of depreciation is measured by the portion of the facilities' total estimated lifetime production that is
produced in that period. For mining assets and properties, the amount of depreciation or depletion is measured by the portion
of the mines' proven and probable mineral reserves recovered during the period.
Depreciation methods, useful lives and residual values are reviewed at each reporting period and are adjusted if appropriate.
iv.
Borrowing costs
Borrowing costs on funds directly attributable to finance the acquisition, production or construction of a qualifying asset are
capitalized until such time as substantially all the activities necessary to prepare the qualifying asset for its intended use are
complete. A qualifying asset is one that takes a substantial period of time to prepare for its intended use. Capitalization is
discontinued when the asset enters the production stage or development ceases. Where the funds used to finance a project
form part of general borrowings, interest is capitalized based on the weighted average interest rate applicable to the general
borrowings outstanding during the period of construction.
v.
Repairs and maintenance
The cost of replacing a component of property, plant and equipment is capitalized if it is probable that future economic benefits
embodied within the component will flow to the Company. The carrying amount of the replaced component is derecognized.
Costs of routine maintenance and repair are charged to products and services sold.
18
I.
Goodwill and intangible assets
Goodwill arising from the acquisition of subsidiaries is initially recognized at cost, measured as the excess of the fair value of
the consideration paid over the fair value of the identifiable net assets acquired. At the date of acquisition, goodwill is allocated
to the cash generating unit (CGU), or group of CGUs that is expected to receive the economic benefits of the business
combination. Goodwill is subsequently measured at cost, less accumulated impairment losses.
Intangible assets acquired individually or as part of a group of assets are initially recognized at cost and measured
subsequently at cost less accumulated amortization and impairment losses. Subsequent expenditure is capitalized only when
it increases the future economic benefits embodied in the specific asset to which it relates. The cost of a group of intangible
assets acquired in a transaction, including those acquired in a business combination that meet the specified criteria for
recognition apart from goodwill, is allocated to the individual assets acquired based on their relative fair values.
Intangible assets that have finite useful lives are amortized over their estimated remaining useful lives. Amortization methods
and useful lives are reviewed at each reporting period and are adjusted if appropriate.
J.
Leases
Cameco recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is
initially measured at cost, which is the initial amount of the lease liability adjusted for any lease payments made at or before
the commencement date, plus any initial direct costs incurred, less any lease incentives received, and subsequently at cost
less any accumulated depreciation and impairment losses. The right-of-use asset is subsequently depreciated using the
straight-line method from the commencement date to the end of the lease term, unless the cost of the right-of-use asset
reflects that the Company will exercise a purchase option, in which case the right-of-use asset will be depreciated on the same
basis as that of property, plant and equipment.
The lease liability is measured at amortized cost using the effective interest method. It is initially measured at the present value
of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease, or,
if that rate cannot be readily determined, the Company’s incremental borrowing rate. Generally, Cameco uses its incremental
borrowing rate as the discount rate. Current borrowing rates available for classes of leased assets are compared with the rates
of Cameco’s existing debt facilities to ensure that use of the Company’s incremental borrowing rate is reasonable.
The lease liability is subsequently increased by the interest cost on the lease liability and decreased by lease payments made.
It is remeasured when there is a change in future lease payments arising from a change in an index or rate, a change in the
estimate of the amount expected to be payable under a residual value guarantee, or as appropriate, changes in the
assessment of whether a purchase or extension option is reasonably certain to be exercised or a termination option is
reasonably certain not to be exercised.
Cameco uses judgement in determining the lease term for some lease contracts that include renewal options. The assessment
of whether the Company is reasonably certain to exercise such options impacts the lease term, which affects the amount of
lease liabilities and right-of-use assets recognized.
The Company has elected not to recognize right-of-use assets and lease liabilities for leases of low-value assets and short-
term leases that have a lease term of 12 months or less. The lease payments associated with these leases are recognized as
an expense on a straight-line basis over the lease term.
K.
Finance income and finance costs
Finance income comprises interest income on funds invested. Interest income and interest expense are recognized in
earnings as they accrue, using the effective interest method. Finance costs comprise interest and fees on borrowings,
unwinding of the discount on provisions and costs incurred on redemption of debentures.
Borrowing costs that are not directly attributable to the acquisition, construction or production of a qualifying asset are
expensed in the period incurred.
19
L.
Research and development costs
Expenditures on research are charged against earnings when incurred. Development costs are recognized as assets when the
Company can demonstrate technical feasibility and that the asset will generate probable future economic benefits.
M.
Impairment
i.
Non-derivative financial assets
Cameco recognizes loss allowances for expected credit losses (ECLs) on financial assets measured at amortized cost, debt
investments measured at FVOCI, and contract assets. It measures loss allowances at an amount equal to lifetime ECLs,
except for debt securities that are determined to have low credit risk at the reporting date and other debt securities, loans
advanced and bank balances for which credit risk has not increased significantly since initial recognition. For these, loss
allowances are measured equal to 12-month ECLs.
Lifetime ECLs are the ECLs that result from all possible default events over the expected life of a financial instrument while 12-
month ECLs are the portion of ECLs that result from default events that are possible within the 12 months after the reporting
date (or a shorter period if the expected life of the instrument is less than 12 months). The maximum period considered when
estimating ECLs is the maximum contractual period over which the Company is exposed to credit risk.
ECLs are a probability-weighted estimate of credit losses. Credit losses are measured as the present value of the difference
between the cash flows due to the entity in accordance with the contract and the cash flows that the Company expects to
receive. ECLs are discounted at the effective interest rate of the financial asset.
When determining whether the credit risk of a financial asset has increased significantly since initial recognition and when
estimating ECLs, the Company considers reasonable and supportable information that is relevant and available without undue
cost or effort. This includes both quantitative and qualitative information and analysis, based on the Company’s historical
experience and informed credit assessment and including forward-looking information.
The Company considers a financial asset to be in default when the borrower is unlikely to pay its credit obligations in full,
without recourse by Cameco to actions such as realizing security (if any is held).
The Company considers a debt security to have low credit risk when it is at least an A (low) DBRS or A- S&P rating.
Financial assets carried at amortized cost and debt securities at FVOCI are assessed at each reporting date to determine
whether they are ‘credit-impaired’. A financial asset is ‘credit-impaired’ when one or more events that have a detrimental effect
on the estimated future cash flows of the financial asset have occurred. Evidence can include significant financial difficulty of
the borrower or issuer, a breach of contract, restructuring of an amount due to the Company on terms that the Company would
not consider otherwise, indications that a debtor or issuer will enter bankruptcy or other financial reorganization, or the
disappearance of an active market for a security.
Loss allowances for financial assets measured at amortized cost are deducted from the gross carrying amount of the assets.
For debt securities at FVOCI, the loss allowance is charged to earnings and is recognized in OCI. The gross carrying amount
of a financial asset is written off when the Company has no reasonable expectations of recovering a financial asset in its
entirety or a portion thereof.
ii.
Non-financial assets
The carrying amounts of Cameco’s non-financial assets are reviewed throughout the year to determine whether there is any
indication of impairment. If any such indication exists, then the asset’s recoverable amount is estimated. Goodwill is tested
annually for impairment.
20
For impairment testing, assets are grouped together into CGUs which are the smallest group of assets that generate cash
inflows from continuing use that are largely independent of the cash inflows of other assets or CGUs. Goodwill arising from a
business combination is allocated to CGUs or groups of CGUs that are expected to benefit from the synergies of the
combination.
The recoverable amount of an asset or CGU is the greater of its value in use and its fair value less costs to sell. Value in use is
based on the estimated future cash flows, discounted to their present value using a pre-tax discount rate that reflects current
market assessments of the time value of money and the risks specific to the asset or CGU. Fair value is determined as the
amount that would be obtained from the sale of the asset or CGU in an arm’s-length transaction between knowledgeable and
willing parties. For exploration properties, fair value is based on the implied fair value of the resources in place using
comparable market transaction metrics.
An impairment loss is recognized if the carrying amount of an asset or its CGU exceeds its recoverable amount. Impairment
losses are recognized in earnings. Impairment losses recognized in respect of CGUs are allocated first to reduce the carrying
amount of any goodwill allocated to the CGU, and then to reduce the carrying amounts of the other assets in the CGU on a pro
rata basis.
Impairment losses recognized in prior periods are assessed throughout the year, whenever events or changes in
circumstances indicate that the impairment may have reversed. If the impairment has reversed, the carrying amount of the
asset is increased to its recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying
amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no
impairment loss had been recognized. A reversal of an impairment loss is recognized immediately in earnings. An impairment
loss in respect of goodwill is not reversed.
N.
Exploration and evaluation expenditures
Exploration and evaluation expenditures are those expenditures incurred by the Company in connection with the exploration
for and evaluation of mineral resources before the technical feasibility and commercial viability of extracting a mineral resource
are demonstrable. These expenditures include researching and analyzing existing exploration data, conducting geological
studies, exploratory drilling and sampling, and compiling prefeasibility and feasibility studies. Exploration and evaluation
expenditures are charged against earnings as incurred, except when there is a high degree of confidence in the viability of the
project and it is probable that these costs will be recovered through future development and exploitation.
The technical feasibility and commercial viability of extracting a resource is considered to be determinable based on several
factors, including the existence of proven and probable reserves and the demonstration that future economic benefits are
probable. When an area is determined to be technically feasible and commercially viable, the exploration and evaluation
assets attributable to that area are first tested for impairment and then transferred to property, plant and equipment.
Exploration and evaluation costs that have been acquired in a business combination or asset acquisition are capitalized under
the scope of IFRS 6, Exploration for and Evaluation of Mineral Resources, and are reported as part of property, plant and
equipment.
O.
Provisions
A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be
estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation. Provisions
are determined by discounting the risk-adjusted expected future cash flows at a pre-tax risk-free rate that reflects current
market assessments of the time value of money. The unwinding of the discount is recognized as a finance cost.
21
i.
Environmental restoration
The mining, extraction and processing activities of the Company normally give rise to obligations for site closure and
environmental restoration. Closure and restoration can include facility decommissioning and dismantling, removal or treatment
of waste materials, as well as site and land restoration. The Company provides for the closure, reclamation and
decommissioning of its operating sites in the financial period when the related environmental disturbance occurs, based on the
estimated future costs using information available at the reporting date. Costs included in the provision comprise all closure
and restoration activity expected to occur gradually over the life of the operation and at the time of closure. Routine operating
costs that may impact the ultimate closure and restoration activities, such as waste material handling conducted as a normal
part of a mining or production process, are not included in the provision.
The timing of the actual closure and restoration expenditure is dependent upon a number of factors such as the life and nature
of the asset, the operating licence conditions and the environment in which the mine operates. Closure and restoration
provisions are measured at the expected value of future cash flows, discounted to their present value using a current pre-tax
risk-free rate. Significant judgments and estimates are involved in deriving the expectations of future activities and the amount
and timing of the associated cash flows.
At the time a provision is initially recognized, to the extent that it is probable that future economic benefits associated with the
reclamation, decommissioning and restoration expenditure will flow to the Company, the corresponding cost is capitalized as
an asset. The capitalized cost of closure and restoration activities is recognized in property, plant and equipment and
depreciated on a unit-of-production basis. The value of the provision is gradually increased over time as the effect of
discounting unwinds. The unwinding of the discount is an expense recognized in finance costs.
Closure and rehabilitation provisions are also adjusted for changes in estimates. The provision is reviewed at each reporting
date for changes to obligations, legislation or discount rates that effect change in cost estimates or life of operations. The cost
of the related asset is adjusted for changes in the provision resulting from changes in estimated cash flows or discount rates,
and the adjusted cost of the asset is depreciated prospectively.
ii.
Waste disposal
The refining, conversion and manufacturing processes generate certain uranium-contaminated waste. The Company has
established strict procedures to ensure this waste is disposed of safely. A provision for waste disposal costs in respect of
these materials is recognized when they are generated. Costs associated with the disposal, the timing of cash flows and
discount rates are estimated both at initial recognition and subsequent measurement.
P.
Employee future benefits
i.
Pension obligations
The Company accrues its obligations under employee benefit plans. The Company has both defined benefit and defined
contribution plans. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a
separate entity. The Company has no legal or constructive obligations to pay further contributions if the fund does not hold
sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods. A defined
benefit plan is a pension plan other than a defined contribution plan. Typically,
defined benefit plans define an amount of
pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of
service and compensation.
22
The liability recognized in the consolidated statements of financial position in respect of defined benefit pension plans is the
present value of the defined benefit obligation at the reporting date less the fair value of plan assets. The defined benefit
obligation is calculated annually, by qualified independent actuaries using the projected unit credit method prorated on service
and management's best estimate of expected plan investment performance, salary escalation, retirement ages of employees
and expected health care costs. The present value of the defined benefit obligation is determined by discounting the estimated
future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the
benefits will be paid, and that have terms to maturity approximating the terms of the related pension liability.
The Company recognizes all actuarial gains and losses arising from defined benefit plans in other comprehensive income, and
reports them in retained earnings. When the benefits of a plan are improved, the portion of the increased benefit relating to
past service by employees is recognized immediately in earnings.
For defined contribution plans, the contributions are recognized as employee benefit expense in earnings in the periods during
which services are rendered by employees. Prepaid contributions are recognized as an asset to the extent that a cash refund
or a reduction in future payments is available.
ii.
Other post-retirement benefit plans
The Company provides certain post-retirement health care benefits to its retirees. The entitlement to these benefits is usually
conditional on the employee remaining in service up to retirement age and the completion of a minimum service period. The
expected costs of these benefits are accrued over the period of employment using the same accounting methodology as used
for defined benefit pension plans. Actuarial gains and losses are recognized in other comprehensive income in the period in
which they arise. These obligations are valued annually by independent qualified actuaries.
iii.
Short-term employee benefits
Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as the related service is
provided. A liability is recognized for the amount expected to be paid under short-term cash bonus plans if the Company has a
present legal or constructive obligation to pay this amount as a result of past service provided by the employee, and the
obligation can be measured reliably.
iv.
Termination benefits
Termination
benefits are payable when employment is terminated by the Company before the normal retirement date, or
whenever an employee accepts an entity’s offer of benefits in exchange for termination of employment. Cameco recognizes
termination benefits as an expense at the earlier of when the Company can no longer withdraw the offer of those benefits and
when the Company recognizes costs for a restructuring. If benefits are payable more than 12 months after the reporting
period, they are discounted to their present value.
v.
Share-based compensation
For equity-settled plans, the grant date fair value of share-based compensation awards granted to employees is recognized as
an employee benefit expense, with a corresponding increase in equity, over the period that the employees unconditionally
become entitled to the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which
the related service and vesting conditions are expected to be met, such that the amount ultimately recognized as an expense
is based on the number of awards that meet the related service and non-market performance conditions at the vesting date.
For cash-settled plans, the fair value of the amount payable to employees is recognized as an expense, with a corresponding
increase in liabilities, over the period that the employees unconditionally become entitled to payment. The liability is re-
measured at each reporting date and at settlement date. Any changes in the fair value of the liability are recognized as
employee benefit expense in earnings.
23
When the terms and conditions of equity-settled plans at the time they were granted are subsequently modified, the fair value
of the share-based payment under the original terms and conditions and under the modified terms and conditions are both
determined at the date of the modification. Any excess of the modified fair value over the original fair value is recognised over
the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based
payment expense is not adjusted if the modified fair value is less than the original fair value.
Cameco’s contributions under the employee share ownership plan are expensed during the year of contribution. Shares
purchased with Company contributions and with dividends paid on such shares become unrestricted on January 1 of the
second plan year following the date on which such shares were purchased.
Q.
Revenue recognition
Cameco supplies uranium concentrates, uranium conversion services, fabrication services and other services. Revenue is
measured based on the consideration specified in a contract with a customer. The Company recognizes revenue when it
transfers control, as described below, over a good or service to a customer. Customers do not have the
right to return
products,
except in limited circumstances.
Cameco’s sales arrangements with its customers are pursuant to enforceable contracts that indicate the nature and timing of
satisfaction of performance obligations, including significant payment terms, where payment is usually due in 30 days. Each
delivery is considered a separate performance obligation under the contract.
Uranium supply
In a uranium supply arrangement, Cameco is contractually obligated to provide uranium concentrates to its customers.
Cameco-owned uranium may be physically delivered to either the customer or to conversion facilities (Converters).
For deliveries to customers, terms in the sales contract specify the location of delivery. Revenue is recognized when the
uranium has been delivered and accepted by the customer at that location.
When uranium is delivered to Converters, the Converter will credit Cameco’s account for the volume of accepted uranium.
Based on delivery terms in the sales contract with its customer, Cameco instructs the Converter to transfer title of a
contractually specified quantity of uranium to the customer’s account at the Converter’s facility. At this point, control has been
transferred and Cameco recognizes revenue for the uranium supply.
Toll conversion services
In a toll conversion arrangement, Cameco is contractually obligated to convert customer-owned uranium to a chemical state
suitable for enrichment. Based on delivery terms in a sales contract with its customer, Cameco either (i) physically delivers
converted uranium to enrichment facilities (Enrichers) where it instructs the Enricher to transfer title of a contractually specified
quantity of converted uranium to the customer’s account at the Enricher’s facility, or (ii) transfers title of a contractually
specified quantity of converted uranium to either an Enricher’s account or the customer’s account at Cameco’s Port Hope
conversion facility. At this point, the customer obtains control and Cameco recognizes revenue for the toll conversion services.
Conversion supply
A conversion supply arrangement is a combination of uranium supply and toll conversion services. Cameco is contractually
obligated to provide converted uranium to its customers. Based on delivery terms in the sales contract, Cameco either (i)
physically delivers converted uranium to the Enricher where it instructs the Enricher to transfer title of a contractually specified
quantity of converted uranium to the customer’s account at the Enricher’s facility, or (ii) transfers title of a contractually
specified quantity of converted uranium to either an Enricher’s account or a customer’s account at Cameco’s Port Hope
conversion facility. At this point, the customer obtains control and Cameco recognizes revenue for both the uranium supplied
and the conversion service provided.
24
Fabrication services
In a fabrication services arrangement, Cameco is contractually obligated to provide fuel bundles or reactor components to its
customers. In a contract for fuel bundles, the bundles are inspected and accepted by the customer at Cameco’s Port Hope
fabrication facility or another location based on delivery terms in the sales contract. At this point, the customer obtains control
and Cameco recognizes revenue for the fabrication services.
In some contracts for reactor components, the components are made to a customer’s specification and if a contract is
terminated by the customer, Cameco is entitled to reimbursement of the costs incurred to date, including a reasonable margin.
Since the customer controls all of the work in progress as the products are being manufactured, revenue and associated costs
are recognized over time, before the goods are delivered to the customer’s premises. Revenue is recognized on the basis of
units produced as the contracts reflect a per unit basis. Revenue from these contracts represents an insignificant portion of
Cameco’s total revenue. In other contracts where the reactor components are not made to a specific customer’s specification,
when the components are delivered to the location specified in the contract, the customer obtains control and Cameco
recognizes revenue for the services.
Other services
Uranium concentrates and converted uranium are regulated products and can only be stored at regulated facilities. In a
storage arrangement, Cameco is contractually obligated to store uranium products at its facilities on behalf of the customer.
Cameco invoices the customer in accordance with the contract terms and recognizes revenue on a monthly basis.
Cameco also provides customers with transportation of its uranium products. In the contractual arrangements where Cameco
is acting as the principal, revenue is recognized as the product is delivered.
R.
Financial instruments
A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity
instrument of another.
Trade receivables and debt securities are initially recognized when they are originated. All other financial assets and liabilities
are initially recognized when the company becomes a party to the contractual provisions of the instrument. A financial asset
(unless it is a trade receivable without a significant financing component) or financial liability is initially measured at fair value
plus, for an item not at fair value through profit or loss, transaction costs that are directly attributable to its acquisition or issue.
A trade receivable without a significant financing component is initially measured at the transaction price.
i.
Financial assets
On initial recognition, financial assets are classified as measured at: amortized cost, fair value through other comprehensive
income, or fair value through profit or loss based on the Company’s business model for managing its financial assets and their
cash flow characteristics. Classifications are not changed subsequent to initial recognition unless the Company changes its
business model for managing its financial assets, in which case all affected financial assets are reclassified on the first day of
the first reporting period following the change in business model.
Amortized cost
A financial asset is measured at amortized cost if it is not designated as at fair value through profit or loss, is held within a
business model whose objective is to hold assets to collect contractual cash flows and its contractual terms give rise to cash
flows on specified dates that are solely payments of principal and interest on the principal amount outstanding. Assets in this
category are subsequently measured at amortized cost using the effective interest method. The amortized cost is reduced by
impairment losses. Interest income, foreign exchange gains and losses and impairment are recognized in profit or loss, as is
any gain or loss on derecognition.
25
Fair value through other comprehensive income (FVOCI)
A debt investment is measured at FVOCI if it is not designated as at fair value through profit or loss, is held within a business
model whose objective is achieved by both collecting contractual cash flows and selling financial assets and its contractual
terms give rise to cash flows on specified dates that are solely payments of principal and interest on the principal amount
outstanding. These assets are subsequently measured at fair value. Interest income calculated using the effective interest
method, foreign exchange gains and losses and impairment are recognized in profit or loss. Other net gains and losses are
recognized in other comprehensive income (OCI). On derecognition, gains and losses accumulated in OCI are reclassified to
profit or loss.
On initial recognition of an equity investment that is not held for trading, Cameco may irrevocably elect to present subsequent
changes in the investments fair value in OCI. This election is made on an investment by investment basis. These assets are
subsequently measured at fair value. Dividends are recognized as income in profit or loss unless the dividend clearly
represents a recovery of part of the cost of the investment. Other net gains and losses are recognized in OCI and are never
reclassified to profit or loss.
Fair value through profit or loss (FVTPL)
All financial assets not classified as measured at amortized cost or FVOCI are measured at FVTPL. This includes all derivative
financial assets. On initial recognition, the Company may irrevocably designate a financial asset that otherwise meets the
requirements to be measured at amortized cost or at FVOCI as at FVTPL if doing so eliminates or significantly reduces an
accounting mismatch that would otherwise arise. These assets are subsequently measured at fair value. Net gains and losses,
including any interest or dividend income, are recognized in profit or loss.
Derecognition of financial assets
Cameco derecognizes a financial asset when the contractual rights to the cash flows from the asset expire, or it transfers the
rights to receive the contractual cash flows in a transaction in which substantially all of the risks and rewards of ownership of
the financial asset are transferred or in which it neither transfers or retains substantially all of the risks and rewards of
ownership and it does not retain control of the financial asset.
If the Company enters into a transaction whereby it transfers assets recognized in its statement of financial position, but
retains either all or substantially all of the risks and rewards of the transferred assets, the transferred assets would not be
derecognized.
ii.
Financial liabilities
On initial recognition, financial liabilities are classified as measured at amortized cost or FVTPL. A financial liability is classified
as FVTPL if it is classified as held-for-trading, is a derivative or is designated as such on initial recognition. Financial liabilities
at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognized in profit or loss.
Other financial liabilities are subsequently measured at amortized cost using the effective interest method. Interest expense
and foreign exchange gains and losses are recognized in profit or loss as is any gain or loss on derecognition.
A financial liability is derecognized when its contractual obligations are discharged or cancelled, or expire. The Company also
derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially
different, in which case a new financial liability based on the modified terms is recognized at fair value. On derecognition of a
financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash
assets transferred or liabilities assumed) is recognized in profit or loss.
iii.
Derivative financial instruments
The Company holds derivative financial instruments to reduce exposure to fluctuations in foreign currency exchange rates and
interest rates. Embedded derivatives are separated from the host contract and accounted for separately if the host contract is
not a financial asset and certain criteria are met.
26
Derivative financial instruments are initially measured at fair value in the consolidated statements of financial position, with any
directly attributable transaction costs recognized in profit or loss as incurred. Subsequent to initial recognition, derivatives are
measured at fair value, and changes in fair value are recognized in profit or loss.
The purpose of hedging transactions is to modify the Company’s exposure to one or more risks by creating an offset between
changes in the fair value of, or the cash flows attributable to, the hedged item and the hedging item. When hedge accounting
is appropriate, the hedging relationship is designated as a fair value hedge, a cash flow hedge, or a foreign currency risk
hedge related to a net investment in a foreign operation. The Company does not have any instruments that have been
designated as hedge transactions at December 31, 2022 and 2021.
S.
Income tax
Income tax expense is comprised of current and deferred taxes. Current tax and deferred tax are recognized in earnings
except to the extent that it relates to a business combination, or items recognized directly in equity or in other comprehensive
income.
Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted or
substantively enacted at the reporting date, and any adjustments to tax payable in respect of previous years. Current tax
assets and liabilities are measured at the amount expected to be paid or recovered from the taxation authorities.
Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for
financial reporting purposes and the amounts used for taxation purposes. In addition, deferred tax is not recognized for taxable
temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected
to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted
by the reporting date. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax
liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on
different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities
will be realized simultaneously.
A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it
is probable that future taxable income will be available against which they can be utilized. Deferred tax assets are reviewed at
each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.
The Company’s exposure to uncertain tax positions is evaluated and a provision is made where it is probable that this
exposure will materialize.
T.
Share capital
Common shares are classified as equity. Incremental costs directly attributable to the issue of common shares are recognized
as a reduction of equity, net of any tax effects.
U.
Earnings per share
The Company presents basic and diluted earnings per share data for its common shares. Earnings per share is calculated by
dividing the net earnings attributable to equity holders of the Company by the weighted average number of common shares
outstanding.
Diluted earnings per share is determined by adjusting the net earnings attributable to equity holders of the Company and the
weighted average number of common shares outstanding, for the effects of all dilutive potential common shares. The
calculation of diluted earnings per share assumes that outstanding options which are dilutive to earnings per share are
exercised and the proceeds are used to repurchase shares of the Company at the average market price of the shares for the
period. The effect is to increase the number of shares used to calculate diluted earnings per share.
27
V.
Segment reporting
An operating segment is a component of the Company that engages in business activities from which it may earn revenues
and incur expenses, including revenues and expenses that relate to transactions with any of the Company’s other segments.
To
be classified as a segment, discrete financial information must be available and operating results must be regularly
reviewed by the Company’s executive team.
Segment capital expenditure is the total cost incurred during the period to acquire property, plant and equipment, and
intangible assets other than goodwill.
W.
Government assistance
Government grants are recognized when there is reasonable assurance that the Company has complied with the relevant
conditions of the grant and that the grant will be received. Grants that compensate the Company for expenses incurred are
recognized in profit or loss as other income on a systematic basis in the periods in which the expenses have been recognized.
3.
Accounting standards
A.
Changes in accounting policy
A number of amendments to existing standards became effective January 1, 2022 but they did not have an effect on the
Company’s financial statements.
B.
New standards and interpretations not yet adopted
A
number of amendments to existing standards are not yet effective for the year ended December 31, 2022 and have not been
applied in preparing these consolidated financial statements. Cameco does not intend to early adopt any of the amendments
and does not expect them to have a material impact on its financial statements.
4.
Determination of fair values
A number of the Company’s accounting policies and disclosures require the measurement of fair value, for both financial and
non-financial assets and liabilities.
The fair value of an asset or liability is generally estimated as the amount that would be received on sale of an asset, or paid to
transfer a liability in an orderly transaction between market participants at the reporting date. Fair values of assets and
liabilities traded in an active market are determined by reference to last quoted prices, in the principal market for the asset or
liability. In the absence of an active market for an asset or liability,
fair values are determined based on market quotes for
assets or liabilities with similar characteristics and risk profiles, or through other valuation techniques. Fair values determined
using valuation techniques require the use of inputs, which are obtained from external, readily observable market data when
available. In some circumstances, inputs that are not based on observable data must be used. In these cases, the estimated
fair values may be adjusted in order to account for valuation uncertainty, or to reflect the assumptions that market participants
would use in pricing the asset or liability.
All fair value measurements are categorized into one of three hierarchy levels, described below, for disclosure purposes. Each
level is based on the transparency of the inputs used to measure the fair values of assets and liabilities:
Level 1 – Values based on unadjusted quoted prices in active markets that are accessible at the reporting date for identical
assets or liabilities.
Level 2 – Values based on quoted prices in markets that are not active or model inputs that are observable either directly or
indirectly for substantially the full term of the asset or liability.
Level 3 – Values based on prices or valuation techniques that require inputs that are both unobservable and significant to the
overall fair value measurement.
28
When the inputs used to measure fair value fall within more than one level of the hierarchy, the level within which the fair value
measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety.
Transfers between levels of the fair value hierarchy are recognized at the end of the reporting period during which the transfer
occurred. There were no transfers between level 1, level 2, or level 3 during the period. Cameco does not have any recurring
fair value measurements that are categorized as level 3 as of the reporting date.
Further information about the techniques and assumptions used to measure fair values is included in the following notes:
Note 6 - Acquisition of additional interest in Cigar Lake Joint Venture (CLJV)
Note 25 - Share-based compensation plans
Note 27 - Financial instruments and risk management
5.
Use of estimates and judgments
The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments,
estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities,
revenues and expenses. Actual results may differ from these estimates.
Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in
the period in which the estimates are revised and in any future period affected.
Information about critical judgments in applying the accounting policies that have the most significant effect on the amounts
recognized in the consolidated financial statements is discussed below. Further details of the nature of these judgments,
estimates and assumptions may be found in the relevant notes to the consolidated financial statements.
A.
Recoverability of long-lived and intangible assets and investments
Cameco assesses the carrying values of property, plant and equipment, intangible assets and investments in associates and
joint ventures when there is an indication of possible impairment. If it is determined that carrying values of assets cannot be
recovered, the unrecoverable amounts are charged against current earnings. Recoverability is dependent upon assumptions
and judgments regarding market conditions, costs of production, sustaining capital requirements, mineral reserves and the
impact of geopolitical events. Other assumptions used in the calculation of recoverable amounts are discount rates, future
cash flows and profit margins. A material change in assumptions may significantly impact the potential impairment of these
assets.
B.
Cash generating units
In performing impairment assessments of long-lived assets, assets that cannot be assessed individually are grouped together
into the smallest group of assets that generates cash inflows that are largely independent of the cash inflows from other assets
or groups of assets. Management is required to exercise judgment in identifying these CGUs.
C.
Provisions for decommissioning and reclamation of assets
Significant decommissioning and reclamation activities are often not undertaken until near the end of the useful lives of the
productive assets. Regulatory requirements and alternatives with respect to these activities are subject to change over time.
A
significant change to either the estimated costs, timing of the cash flows or mineral reserves may result in a material change in
the amount charged to earnings.
29
D.
Income taxes
Cameco operates in a number of tax jurisdictions and is, therefore, required to estimate its income taxes in each of these tax
jurisdictions in preparing its consolidated financial statements. In calculating income taxes, consideration is given to factors
such as tax rates in the different jurisdictions, non-deductible expenses, changes in tax law and management’s expectations of
future operating results. Cameco estimates deferred income taxes based on temporary differences between the income and
losses reported in its consolidated financial statements and its taxable income and losses as determined under the applicable
tax laws. The tax effect of these temporary differences is recorded as deferred tax assets or liabilities in the consolidated
financial statements. The calculation of income taxes requires the use of judgment and estimates. The determination of the
recoverability of deferred tax assets is dependent on assumptions and judgments regarding future market conditions and
production rates, which can materially impact estimated future taxable income. If these judgments and estimates prove to be
inaccurate, future earnings may be materially impacted.
E.
Mineral reserves
Depreciation on property, plant and equipment is primarily calculated using the unit-of-production method. This method
allocates the cost of an asset to each period based on current period production as a portion of total lifetime production or a
portion of estimated mineral reserves. Estimates of life-of-mine and amounts of mineral reserves are updated annually and are
subject to judgment and significant change over time. If actual mineral reserves prove to be significantly different than the
estimates, there could be a material impact on the amounts of depreciation charged to earnings.
6.
Acquisition of additional interest in Cigar
Lake Joint Venture (CLJV)
On May 19, 2022, Cameco and Orano Canada Inc. (Orano) completed the acquisition of Idemitsu Canada Resources Ltd.’s
(Idemitsu)
7.875
% participating interest in the CLJV by acquiring their pro rata shares through an asset purchase. Cameco’s
ownership stake in the Cigar Lake uranium mine in northern Saskatchewan is now
54.547
% (previously
50.025
%). The
primary reason for the business combination was to increase our ownership interest.
Cash consideration of $
101,681,000
was paid for the additional
4.522
% interest. At December 31, 2022, $
3,000,000
remained
in escrow, to be paid upon finalization of closing adjustments. While Cameco received the economic benefit of owning the
additional interest as of January 1, 2022, the additional interest has been proportionately consolidated with the results of
Cameco commencing on May 19, 2022.
CLJV allocates uranium production to each joint operation participant and the joint operation participant derives revenue
directly from the sale of such product. Mining and milling expenses incurred by joint operations are included in the cost of
inventory. As such, there is no revenue or profit or loss of the acquiree included in the consolidated statements of earnings. If
the acquisition had occurred at the beginning of the year, Cameco’s share of production would have included an additional
296,000
pounds. The impact to the financial statements would not have been material.
Acquisition costs of $
1,495,000
have been included in administration expense in the consolidated statements of earnings for
the year ended December 31, 2022.
30
Included in the identifiable assets and liabilities acquired at the date of acquisition are inputs, production processes and
outputs. Therefore, Cameco has determined that together the acquired set is a business. In accordance with the acquisition
method of accounting, the purchase price was allocated to the underlying assets and liabilities assumed based on their fair
values at the date of acquisition. Fair values were determined based on discounted cash flows and quoted market prices. The
values assigned to the net assets acquired were as follows:
Property, plant and equipment
$
97,930
Deferred tax asset
(a)
28,196
Inventory
9,909
Working capital
(24)
Reclamation provision
(2,528)
Sales contracts
(9,000)
Net assts acquired
$
124,483
Cash paid
101,681
Bargain purchase gain
(b)
$
22,802
(a)
The deferred tax asset has been measured provisionally, pending further review of the income tax attributes of the
acquisition.
(b)
The preliminary bargain purchase gain resulted from applying the measurement requirements under IFRS 3,
Business
Combinations
. This standard requires the measurement of tax attributes that were acquired as part of the transaction be in
accordance with IAS 12,
Income Taxes
, rather than at fair value. The measured amount of these attributes exceeded the
amount paid for them and the resulting gain is included in other income (expense) in the consolidated statement of earnings.
The accounting for the acquisition will be revised if, within one year of the acquisition date, new information is obtained about
facts and circumstances that existed at the date of acquisition. Revision will occur if this new information identifies adjustments
to the above amounts, or any additional provisions that existed at the date of acquisition.
7.
Accounts receivable
2022
2021
Trade receivables
$
167,688
$
271,015
GST/VAT
receivables
5,856
3,919
Other receivables
10,400
1,205
Total
$
183,944
$
276,139
The Company’s exposure to credit and currency risks as well as credit losses related to trade and other receivables, excluding
goods and services tax (GST)/value added tax (VAT)
receivables, is disclosed in note 27.
31
8.
Inventories
2022
2021
Uranium
Concentrate
$
537,426
$
319,257
Broken ore
46,703
46,324
584,129
365,581
Fuel services
80,144
43,549
Other
425
391
Total
$
664,698
$
409,521
Cameco expensed $
1,359,000,000
of inventory as cost of sales during 2022 (2021 - $
1,218,000,000
).
9.
Property, plant and equipment
At December 31, 2022
Land
Plant
Furniture
Exploration
and
and
and
Under
and
buildings
equipment
fixtures
construction
evaluation
Total
Cost
Beginning of year
$
5,152,209
$
2,732,561
$
84,366
$
167,200
$
1,073,239
$
9,209,575
Acquisitions [note 6]
67,998
27,646
70
2,216
-
97,930
Additions
4,385
8,927
209
129,734
193
143,448
Transfers
25,023
39,091
(167)
(63,518)
-
429
Change in reclamation provision [note 16]
(93,451)
-
-
-
-
(93,451)
Disposals
(4,885)
(8,423)
(650)
(1,046)
-
(15,004)
Effect of movements in exchange rates
45,859
12,507
252
4
14,802
73,424
End of year
5,197,138
2,812,309
84,080
234,590
1,088,234
9,416,351
Accumulated depreciation and impairment
Beginning of year
3,101,740
1,962,228
78,119
36,798
458,247
5,637,132
Depreciation charge
137,543
101,923
1,857
-
-
241,323
Change in reclamation provision [note 16]
(a)
22,944
-
-
-
-
22,944
Disposals
(4,851)
(8,201)
(649)
-
-
(13,701)
Effect of movements in exchange rates
43,493
12,049
249
-
8,824
64,615
End of year
3,300,869
2,067,999
79,576
36,798
467,071
5,952,313
Right-of-use assets
Beginning of year
931
1,584
1,641
-
-
4,156
Additions
5,917
1,330
606
-
-
7,853
Disposals
-
(11)
-
-
-
(11)
Depreciation charge
(870)
(560)
(687)
-
-
(2,117)
Transfers
(19)
(778)
368
-
-
(429)
End of year
5,959
1,565
1,928
-
-
9,452
Net book value at December 31, 2022
$
1,902,228
$
745,875
$
6,432
$
197,792
$
621,163
$
3,473,490
32
At December 31, 2021
Land
Plant
Furniture
Exploration
and
and
and
Under
and
buildings
equipment
fixtures
construction
evaluation
Total
Cost
Beginning of year
$
5,224,333
$
2,699,844
$
78,911
$
139,051
$
1,125,483
$
9,267,622
Additions
1,520
8,807
700
87,637
120
98,784
Transfers
17,145
31,243
5,130
(52,797)
-
721
Change in reclamation provision
(62,427)
-
-
-
-
(62,427)
Disposals
(23,075)
(6,019)
(345)
(6,691)
-
(36,130)
Effect of movements in exchange rates
(5,287)
(1,314)
(30)
-
(52,364)
(58,995)
End of year
5,152,209
2,732,561
84,366
167,200
1,073,239
9,209,575
Accumulated depreciation and impairment
Beginning of year
3,031,292
1,876,336
74,246
36,798
483,663
5,502,335
Depreciation charge
104,641
92,670
4,246
-
-
201,557
Change in reclamation provision
(a)
(8,407)
-
-
-
-
(8,407)
Disposals
(20,999)
(5,623)
(345)
-
-
(26,967)
Effect of movements in exchange rates
(4,787)
(1,155)
(28)
-
(25,416)
(31,386)
End of year
3,101,740
1,962,228
78,119
36,798
458,247
5,637,132
Right-of-use assets
Beginning of year
1,806
2,322
2,142
-
-
6,270
Additions
-
477
-
-
-
477
Depreciation charge
(875)
(494)
(501)
-
-
(1,870)
Transfers
-
(721)
-
-
-
(721)
End of year
931
1,584
1,641
-
-
4,156
Net book value at December 31, 2021
$
2,051,400
$
771,917
$
7,888
$
130,402
$
614,992
$
3,576,599
Cameco has contractual capital commitments of approximately $
56,500,000
at December 31, 2022. Certain of the contractual
commitments may contain cancellation clauses, however the Company discloses the commitments based on management’s
intent to fulfill the contract. The majority of this amount is expected to be incurred in 2023.
(a) Asset retirement obligation assets are adjusted when the Company updates its reclamation provisions due to new cash
flow estimates or changes in discount and inflation rates. When the assets of an operation have been written off due to an
impairment, as is the case with our Rabbit Lake operation and some of our operations in the United States, the adjustment is
recorded directly to the statement of earnings as other operating expense or income.
33
10.
Intangible assets
A.
Reconciliation of carrying amount
At December 31, 2022
Intellectual
Contracts
property
Total
Cost
Beginning of year
$
110,618
$
118,819
$
229,437
Effect of movements in exchange rates
8,027
-
8,027
End of year
118,645
118,819
237,464
Accumulated amortization and impairment
Beginning of year
109,886
68,304
178,190
Amortization charge
739
3,454
4,193
Effect of movements in exchange rates
7,964
-
7,964
End of year
118,589
71,758
190,347
Net book value at December 31, 2022
$
56
$
47,061
$
47,117
At December 31, 2021
Intellectual
Contracts
property
Total
Cost
Beginning of year
$
111,388
$
118,819
$
230,207
Effect of movements in exchange rates
(770)
-
(770)
End of year
110,618
118,819
229,437
Accumulated amortization and impairment
Beginning of year
109,663
64,722
174,385
Amortization charge
975
3,582
4,557
Effect of movements in exchange rates
(752)
-
(752)
End of year
109,886
68,304
178,190
Net book value at December 31, 2021
$
732
$
50,515
$
51,247
B.
Amortization
The intangible asset values relate to intellectual property acquired with Cameco Fuel Manufacturing Inc. (CFM) and purchase
and sales contracts acquired with NUKEM. The CFM intellectual property is being amortized on a unit-of-production basis over
its remaining life. Amortization is allocated to the cost of inventory and is recognized in cost of products and services sold as
inventory was sold. The purchase and sales contracts were amortized to earnings over the terms of the underlying contracts.
Amortization of the purchase contracts was allocated to the cost of inventory and included in cost of products and services
sold as inventory was sold. Sales contracts were amortized to revenue.
34
11.
Long-term receivables, investments and other
2022
2021
Deferred charges
$
29,585
$
-
Derivatives [note 27]
2,807
32,098
Investment tax credits
95,812
95,722
Amounts receivable related to tax dispute [note 22]
(a)
295,221
295,221
Product loan
(b)
200,998
176,904
Other
3,264
814
627,687
600,759
Less current portion
(32,180)
(23,232)
Net
$
595,507
$
577,527
(a)
Cameco was required to remit or otherwise secure 50% of the cash taxes and transfer pricing penalties, plus related
interest and instalment penalties assessed, in relation to its dispute with Canada Revenue Agency (CRA) (see note 22). In
light of our view of the likely outcome of the case, Cameco expects to recover the amounts remitted to CRA, including cash
taxes, interest and penalties totalling $
295,221,000
already paid as at December 31, 2022 (December 31, 2021 -
$
295,221,000
) (note 22).
(b)
Cameco loaned
5,400,000
pounds of uranium concentrate to its joint venture partner, Orano Canada Inc., (Orano). Orano
was obligated to repay the Company in kind with uranium concentrate no later than December 31, 2023. During the first
quarter of 2022, the repayment terms were extended to
December 31, 2028
. During 2022,
1,828,999
pounds were returned as
repayment on this loan.
Cameco also agreed to lend to Orano up to
1,148,200
kgU of conversion supply and up to an additional
1,200,000
pounds of
uranium concentrate over the period 2022 to 2024. Repayment to Cameco is to be made in kind with U
3
O
8
quantities drawn
being repaid by
December 31, 2027
and quantities of UF
6
drawn by
December 31, 2035
.
As at December 31, 2022,
3,571,001
pounds of U
3
O
8
and
700,000
kgU of UF
6
conversion supply were drawn on the loans and
are recorded at Cameco’s weighted average cost of inventory.
12.
Equity-accounted investee
JV Inkai is the operator of the Inkai uranium deposit located in Kazakhstan. Cameco holds a
40
% interest and Kazatomprom
holds a
60
% interest in JV Inkai. Cameco does not have joint control over the joint venture and as a result, Cameco accounts
for JV Inkai on an equity basis.
JV Inkai is a uranium mining and milling operation that utilizes in-situ recovery (ISR) technology to extract uranium. The
participants in JV Inkai purchase uranium from Inkai and, in turn, derive revenue directly from the sale of such product to third-
party customers.
The following tables summarize the financial information of JV Inkai (100%):
2022
2021
Cash and cash equivalents
$
14,950
$
12,893
Other current assets
373,868
301,589
Non-current assets
334,954
328,469
Current liabilities
(34,606)
(32,774)
Non-current liabilities
(37,644)
(38,635)
Net assets
$
651,522
$
571,542
35
2022
2021
Revenue from products and services
$
476,354
$
387,319
Cost of products and services sold
(66,119)
(55,397)
Depreciation and amortization
(24,749)
(25,300)
Finance income
1,341
349
Finance costs
(2,635)
(796)
Other expense
(30,770)
(16,636)
Income tax expense
(74,763)
(60,357)
Net earnings
278,659
229,182
Total comprehensive income
$
278,659
$
229,182
The following table reconciles the summarized financial information to the carrying amount of Cameco’s interest in JV Inkai:
2022
2021
Opening net assets
$
571,542
$
440,565
Total
comprehensive income
278,659
229,182
Dividends declared
(195,865)
(85,198)
Impact of foreign exchange
(2,814)
(13,007)
Closing net assets
651,522
571,542
Cameco's share of net assets
260,609
228,617
Consolidating adjustments
(a)
(82,275)
(60,348)
Fair value increment
(b)
83,675
85,976
Dividends in excess of ownership percentage
(c)
(48,641)
(22,085)
Impact of foreign exchange
(2,396)
1,080
Carrying amount in the statement of financial position
$
210,972
$
233,240
(a) Cameco records certain consolidating adjustments to eliminate unrealized profit and amortize historical differences in
accounting policies. This amount is amortized to earnings over units of production.
(b) Upon restructuring, Cameco assigned fair values to the assets and liabilities of JV Inkai. This increment is amortized to
earnings over units of production.
(c) Cameco’s share of dividends follows its production purchase entitlements which is currently higher than its ownership
interest.
13.
Accounts payable and accrued liabilities
2022
2021
Trade payables
$
249,962
$
213,377
Non-trade payables
65,182
66,048
Payables due to related parties [note 25]
59,570
61,033
Total
$
374,714
$
340,458
The Company’s exposure to currency and liquidity risk related to trade and other payables is disclosed in note 27.
36
14.
Long-term debt
2022
2021
Unsecured debentures
Series F -
5.09
% debentures due
November 14, 2042
99,355
99,336
Series G -
4.19
% debentures due
June 24, 2024
499,407
499,010
Series H -
2.95
% debentures due
October 21, 2027
398,238
397,904
Total
$
997,000
$
996,250
Cameco has a $
1,000,000,000
unsecured revolving credit facility that is available until
October 1, 2026
. Upon mutual
agreement, the facility can be extended for an additional year on the anniversary date. In addition to direct borrowings under
the facility, up to $
100,000,000
can be used for the issuance of letters of credit and, to the extent necessary, it may be used to
provide liquidity support for the Company’s commercial paper program. The agreement also provides the ability to increase the
revolving credit facility above $
1,000,000,000
by increments no less than $
50,000,000
, to a total of $
1,250,000,000
. The
facility ranks equally with all of Cameco’s other senior debt. As of December 31, 2022 and 2021, there were
no
amounts
outstanding under this facility.
Cameco has $
1,756,754,000
(2021 - $
1,696,041,000
) in letter of credit facilities. Outstanding and committed letters of credit at
December 31, 2022 amounted to $
1,593,379,000
(2021 - $
1,573,873,000
), the majority of which relate to future
decommissioning and reclamation liabilities (note 16).
Cameco is bound by a covenant in its revolving credit facility. The covenant requires a funded debt to tangible net worth ratio
equal to or less than
1
:1. Non-compliance with this covenant could result in accelerated payment and termination of the
revolving credit facility. At December 31, 2022, Cameco was in compliance with the covenant and does not expect its
operating and investing activities in 2023 to be constrained by it.
The table below represents currently scheduled maturities of long-term debt:
2023
2024
2025
2026
2027
Thereafter
Total
$
-
499,407
-
-
398,238
99,355
$
997,000
15.
Other liabilities
2022
2021
Deferred sales [note 18]
$
66,845
$
23,316
Derivatives [note 27]
58,342
4,997
Accrued pension and post-retirement benefit liability [note 26]
66,180
89,002
Lease obligation
9,287
4,872
Product loan
(a)
78,094
15,763
Sales contracts [note 6]
9,000
-
Other
59,738
56,615
347,486
194,565
Less: current portion
(131,324)
(22,791)
Net
$
216,162
$
171,774
Expenses related to short-term leases and leases of low-value assets were insignificant during 2022
.
37
(a) The Company has standby product loan facilities with various counterparties. The arrangements allow it to borrow up to
2,438,000
kgU of UF
6
conversion services and
2,817,000
pounds of U
3
O
8
by September 30, 2026 with repayment in kind up to
December 31, 2026
. Under the facilities, standby fees of up to
1
% are payable based on the market value of the facilities and
interest is payable on the market value of any amounts drawn at rates ranging from
0.5
% to
2.0
%. At December 31, 2022, we
have
1,529,000
kgU of UF
6
conversion services drawn on the loans with repayment by December 31 of the following years:
2023
2024
2025
2026
Total
kgU of UF
6
331,000
-
287,000
911,000
1,529,000
We also have
1,393,000
pounds of U
3
O
8
drawn with repayment due no later than December 31, 2023 of the following years:
2023
2024
2025
2026
Total
lbs of U
3
O
8
1,150,000
-
-
243,000
1,393,000
The loans are recorded at Cameco’s weighted average cost of inventory.
16.
Provisions
Reclamation
Waste disposal
Total
Beginning of year
$
1,126,969
$
9,405
$
1,136,374
Changes in estimates and discount rates [note 9]
Capitalized in property, plant and equipment
(116,395)
-
(116,395)
Recognized in earnings [note 9]
22,944
1,564
24,508
Acquisitions [note 6]
2,528
-
2,528
Provisions used during the period
(27,159)
(1,333)
(28,492)
Unwinding of discount [note 20]
28,681
298
28,979
Effect of movements in exchange rates
23,528
-
23,528
End of period
$
1,061,096
$
9,934
$
1,071,030
Current
$
46,004
$
2,301
$
48,305
Non-current
1,015,092
7,633
1,022,725
$
1,061,096
$
9,934
$
1,071,030
The reclamation provision decreased by $
90,923,000
due largely to an increase in risk-free nominal and implied inflation rates
during the year.
A.
Reclamation provision
Cameco's estimates of future decommissioning obligations are based on reclamation standards that satisfy regulatory
requirements. Elements of uncertainty in estimating these amounts include potential changes in regulatory requirements,
decommissioning and reclamation alternatives and amounts to be recovered from other parties.
Cameco estimates total undiscounted future decommissioning and reclamation costs for its existing operating assets to be
$
1,356,092,000
(2021 - $
1,100,378,000
). The expected timing of these outflows is based on life-of-mine plans with the
majority of expenditures expected to occur after
2028
. These estimates are reviewed by Cameco technical personnel as
required by regulatory agencies or more frequently as circumstances warrant. In connection with future decommissioning and
reclamation costs, Cameco has provided financial assurances of $
1,035,348,000
(2021 - $
1,007,009,000
) in the form of letters
of credit to satisfy current regulatory requirements.
38
The reclamation provision relates to the following segments:
2022
2021
Uranium
$
870,877
$
900,482
Fuel services
190,219
226,487
Total
$
1,061,096
$
1,126,969
B.
Waste disposal
The fuel services segment consists of the Blind River refinery, Port Hope conversion facility and Cameco Fuel Manufacturing
Inc.. The refining, conversion and manufacturing processes generate certain uranium contaminated waste. These include
contaminated combustible material (paper, rags, gloves, etc.) and contaminated non-combustible material (metal parts, soil
from excavations, building and roofing materials, spent uranium concentrate drums, etc.). These materials can in some
instances be recycled or reprocessed. A provision for waste disposal costs in respect of these materials is recognized when
they are generated.
Cameco estimates total undiscounted future costs related to existing waste disposal to be $
8,919,000
(2021 - $
8,169,000
).
The majority of these expenditures are expected to occur within the next four years.
17.
Share capital
Authorized share capital:
-
Unlimited number of first preferred shares
-
Unlimited number of second preferred shares
-
Unlimited number of voting common shares,
no
stated par value, not convertible or redeemable, and
-
One Class B share
A.
Common Shares
Number issued
(number of shares)
2022
2021
Beginning of year
398,059,265
396,262,741
Issued:
Stock option plan [note 25]
401,955
1,796,524
Equity issuance
(a)
34,057,250
-
End of year
432,518,470
398,059,265
(a) On October 17, 2022, Cameco issued
34,057,250
common shares pursuant to a public offering for a total consideration of
$
996,867,000
. The proceeds of the issue after deducting expenses were $
964,878,000
. Excluding the deferred tax recoveries,
the net cash proceeds amounted to $
953,285,000
.
All issued shares are fully paid. Holders of the common shares are entitled to exercise one vote per share at meetings of
shareholders, are entitled to receive dividends if, as and when declared by our Board of Directors and are entitled to
participate in any distribution of remaining assets following a liquidation.
The shares of Cameco are widely held and
no shareholder, resident in Canada, is allowed to own more than 25% of the
Company’s outstanding common shares, either individually or together with associates. A non-resident of Canada is not
allowed to own more than 15%. In addition, no more than 25% of total shareholder votes cast may be cast by non-resident
shareholders.
39
B.
Class B share
One Class B share issued during 1988 and assigned $
1
of share capital
entitles the shareholder to vote separately as a class
in respect of any proposal to locate the head office of Cameco to a place not in the province of Saskatchewan
.
C.
Dividends
Dividends on Cameco Corporation common shares are declared in Canadian dollars. For the year ended December 31, 2022,
the dividend declared per share was $
0.12
(December 31, 2021 - $
0.08
).
18.
Revenue
Cameco’s sales contracts with customers contain both fixed and market-related pricing. Fixed-price contracts are typically
based on a term-price indicator at the time the contract is accepted and escalated over the term of the contract. Market-related
contracts are based on either the spot price or long-term price, and the price is quoted at the time of delivery rather than at the
time the contract is accepted. These contracts often include a floor and/or ceiling prices, which are usually escalated over the
term of the contract. Escalation is generally based on a consumer price index. The Company’s contracts contain either one of
these pricing mechanisms or a combination of the two. There is no variable consideration in the contracts and therefore no
revenue is considered constrained at the time of delivery. Cameco expenses the incremental costs of obtaining a contract as
incurred as the amortization period is less than a year.
The following table summarizes Cameco’s sales disaggregated by geographical region and contract type and includes a
reconciliation to the Company’s reportable segments (note 29):
For the year ended December 31, 2022
Uranium
Fuel services
Other
Total
Customer geographical region
Americas
$
806,915
$
289,028
$
20,025
$
1,115,968
Europe
284,602
52,112
2,769
339,483
Asia
388,629
23,923
-
412,552
$
1,480,146
$
365,063
$
22,794
$
1,868,003
Contract type
Fixed-price
$
478,552
$
355,479
$
22,794
$
856,825
Market-related
1,001,594
9,584
-
1,011,178
$
1,480,146
$
365,063
$
22,794
$
1,868,003
For the year ended December 31, 2021
Uranium
Fuel services
Other
Total
Customer geographical region
Americas
$
547,257
$
287,802
$
12,769
$
847,828
Europe
218,879
77,110
2,945
298,934
Asia
288,857
39,365
-
328,222
$
1,054,993
$
404,277
$
15,714
$
1,474,984
Contract type
Fixed-price
$
307,858
$
384,065
$
11,421
$
703,344
Market-related
747,135
20,212
4,293
771,640
$
1,054,993
$
404,277
$
15,714
$
1,474,984
40
Deferred sales
The following table provides information about contract liabilities (note 15) from contracts with customers:
2022
2021
Beginning of year
$
23,316
$
14,382
Additions
45,978
16,531
Recognized in revenue
(2,463)
(7,596)
Effect of movements in exchange rates
14
(1)
End of year
$
66,845
$
23,316
Deferred sales primarily relates to advance consideration received from customers for future uranium and conversion
deliveries as well as revenue related to the storage of uranium and converted uranium held at Cameco facilities.
The revenue
related to storage is recognized over time while the revenue related to future uranium and conversion deliveries is expected to
be recognized between 2023 and 2030.
Cameco recognized a decrease of revenue of $
194,000
(2021 - increase of revenue of $
383,000
) during 2022 from
performance obligations satisfied (or partially satisfied) in previous periods. This is due to the difference between actual pricing
indices and the estimates at the time of invoicing.
Future sales commitments
Cameco’s sales portfolio consists of short and long-term sales commitments. The contracts can be executed well in advance
of a delivery and include both fixed and market-related pricing.
The following table summarizes the expected future revenue,
by segment, related to only fixed-price contracts with remaining future deliveries as follows:
2023
2024
2025
2026
2027
Thereafter
Total
Uranium
$
556,122
$
629,675
$
627,534
$
237,052
$
238,354
$
622,034
$
2,910,771
Fuel services
339,355
355,915
329,091
244,236
235,089
1,016,232
2,519,918
Total
$
895,477
$
985,590
$
956,625
$
481,288
$
473,443
$
1,638,266
$
5,430,689
The sales contracts are denominated largely in US dollars and converted from US to Canadian dollars at a rate of $
1.30
.
The amounts in the table represent the consideration the Company will be entitled to receive when it satisfies the remaining
performance obligations in the contracts. The amounts include assumptions about volumes for contracts that have volume
flexibility. Cameco’s total revenue that will be earned will also include revenue from contracts with market-related pricing. The
Company has elected to exclude these amounts from the table as the transaction price will not be known until the time of
delivery. Contracts with an original duration of one year or less have been included in the table.
41
19.
Employee benefit expense
The following employee benefit expenses are included in cost of products and services sold, administration, exploration,
research and development and property, plant and equipment:
2022
2021
Wages and salaries
$
278,980
$
236,181
Statutory and company benefits
52,247
43,870
Expenses related to defined benefit plans [note 26]
5,656
5,350
Expenses related to defined contribution plans [note 26]
15,189
12,939
Equity-settled share-based compensation [note 25]
6,859
7,837
Cash-settled share-based compensation [note 25]
24,369
41,839
Total
$
383,300
$
348,016
20.
Finance costs
2022
2021
Interest on long-term debt
$
40,059
$
39,266
Unwinding of discount on provisions [note 16]
28,979
21,445
Other charges
16,690
15,901
Total
$
85,728
$
76,612
No
borrowing costs were determined to be eligible for capitalization during the year.
21.
Other income (expense)
2022
2021
Foreign exchange gains
74,132
446
Government assistance
(a)
-
21,209
Bargain purchase gain [note 6]
22,802
-
Other
-
(302)
Total
$
96,934
$
21,353
(a)
In response to the negative economic impact of COVID-19, the Government of Canada announced the Canada
Emergency Wage Subsidy program (CEWS). CEWS provides a subsidy on eligible remuneration based on certain criteria. In
2021, the Company qualified for the subsidy for the periods January through June.
There were no unfulfilled conditions and
other contingencies attached to this government assistance.
42
22.
Income taxes
A.
Significant components of deferred tax assets and liabilities
Recognized in earnings
As at December 31
2022
2021
2022
2021
Assets
Property, plant and equipment
$
84,668
$
82,677
$
448,136
$
363,468
Provision for reclamation
(3,817)
(14,509)
203,816
207,633
Inventories
1,689
2,489
8,248
6,559
Foreign exploration and development
(1,816)
(812)
2,641
4,457
Income tax losses (gains)
(66,227)
(80,802)
235,683
301,910
Defined benefit plan actuarial losses
-
-
2,698
8,126
Long-term investments and other
(2,355)
16,405
82,849
45,426
Deferred tax assets
12,142
5,448
984,071
937,579
Liabilities
Property, plant and equipment
-
-
-
-
Inventories
-
-
-
-
Deferred tax liabilities
-
-
-
-
Net deferred tax asset
$
12,142
$
5,448
$
984,071
$
937,579
Deferred tax allocated as
2022
2021
Deferred tax assets
$
984,071
$
937,579
Deferred tax liabilities
-
-
Net deferred tax asset
$
984,071
$
937,579
Cameco has recorded a deferred tax asset of $
984,071,000
(2021 - $
937,579,000
). The realization of this deferred tax asset is
dependent upon the generation of future taxable income in certain jurisdictions during the periods in which the Company’s
deferred tax assets are available. The Company considers whether it is probable that all or a portion of the deferred tax assets
will not be realized. In making this assessment, management considers all available evidence, including recent financial
operations, projected future taxable income and tax planning strategies. Based on projections of future taxable income over
the periods in which the deferred tax assets are available, realization of these deferred tax assets is probable and
consequently the deferred tax assets have been recorded.
43
B.
Movement in net deferred tax assets and liabilities
2022
2021
Deferred tax asset at beginning of year
$
937,579
$
936,678
Recovery for the year in net earnings
12,142
5,448
Recovery for the year in equity
11,593
-
Recovery for the year in purchase price equation
28,196
-
Expense for the year in other comprehensive income
(5,440)
(4,541)
Effect of movements in exchange rates
1
(6)
End of year
$
984,071
$
937,579
C.
Significant components of unrecognized deferred tax assets
2022
2021
Income tax losses
$
337,749
$
288,637
Property, plant and equipment
2,297
2,209
Provision for reclamation
78,336
66,573
Long-term investments and other
18,628
58,330
Total
$
437,010
$
415,749
D.
Tax rate reconciliation
The provision for income taxes differs from the amount computed by applying the combined expected federal and provincial
income tax rate to earnings before income taxes. The reasons for these differences are as follows:
2022
2021
Earnings (loss) before income taxes and non-controlling interest
$
84,795
$
(103,855)
Combined federal and provincial tax rate
26.9%
26.9%
Computed income tax expense (recovery)
22,810
(27,937)
Increase (decrease) in taxes resulting from:
Difference between Canadian rates and rates
applicable to subsidiaries in other countries
8,986
28,690
Change in unrecognized deferred tax assets
1,234
22,068
Income in equity-accounted investee
(25,264)
(24,481)
Change in uncertain tax positions
(6,282)
1,099
Bargain purchase gain
(6,129)
-
Other permanent differences
176
(640)
Income tax recovery
$
(4,469)
$
(1,201)
44
E.
Earnings and income taxes by jurisdiction
2022
2021
Earnings (loss) before income taxes
Canada
$
99,944
$
58,624
Foreign
(15,149)
(162,479)
$
84,795
$
(103,855)
Current income taxes
Canada
$
2,260
$
2,257
Foreign
5,413
1,990
$
7,673
$
4,247
Deferred income tax recovery
Canada
$
(10,178)
$
(3,937)
Foreign
(1,964)
(1,511)
$
(12,142)
$
(5,448)
Income tax recovery
$
(4,469)
$
(1,201)
F.
Reassessments
Canada
On February 18, 2021, the Supreme Court of Canada (Supreme Court) dismissed Canada Revenue Agency’s (CRA)
application for leave to appeal the June 26, 2020 decision of the Federal Court of Appeal (Court of Appeal). The dismissal
means that the dispute for the 2003, 2005 and 2006 tax years is fully and finally resolved in the Company’s favour.
In September 2018, the Tax
Court of Canada (Tax Court) ruled that the marketing and trading structure involving foreign
subsidiaries, as well as the related transfer pricing methodology used for certain intercompany uranium sales and purchasing
agreements, were in full compliance with Canadian law for the tax years in question. Management believes the principles in
the decision apply to all subsequent tax years, and that the ultimate resolution of those years will not be material to Cameco’s
financial position, results of operations or liquidity in the year(s) of resolution.
The total tax reassessed for the three tax years was $
11,000,000
, and Cameco remitted
50
%. In 2021, Cameco received
refunds totaling about $
5,500,000
plus interest.
In addition, on April 30, 2019, the Tax Court had awarded Cameco $
10,300,000
for legal fees incurred, plus an amount for
disbursements of up to $
16,700,000
. As a result of additional information provided by the Tax Court, $
12,200,000
for
disbursements was recognized as a reduction of administration expense in 2021.
If CRA continues to pursue reassessments for tax years subsequent to 2006, Cameco will continue to utilize its appeal rights
under Canadian federal and provincial tax rules.
45
G.
Income tax losses
At December 31, 2022, income tax losses carried forward of $
2,171,825,000
(2021 - $
2,177,025,000
) are available to reduce
taxable income. These losses expire as follows:
Date of expiry
Canada
US
Other
Total
2026
$
-
$
-
$
14,720
$
14,720
2027
-
-
243
243
2028
-
-
63
63
2029
47
-
12,625
12,672
2031
-
21,768
-
21,768
2032
272
23,444
-
23,716
2033
-
36,033
-
36,033
2034
-
16,724
4,526
21,250
2035
282,522
7,622
7,233
297,377
2036
210,591
46,621
5,698
262,910
2037
27
34,921
2,985
37,933
2038
500
37,660
320
38,480
2039
6,423
29,130
335
35,888
2040
3,110
55,775
-
58,885
2041
77
229,464
-
229,541
2042
49
22,577
-
22,626
No expiry
-
-
1,057,720
1,057,720
$
503,618
$
561,739
$
1,106,468
$
2,171,825
Included in the table above is $
1,329,261,000
(2021 - $
1,083,848,000
) of temporary differences related to loss carry forwards
where no future benefit has been recognized.
23.
Per share amounts
Per share amounts have been calculated based on the weighted average number of common shares outstanding during the
period. The weighted average number of paid shares outstanding in 2022 was
405,494,353
(2021 -
397,630,947
).
2022
2021
Basic earnings (loss) per share computation
Net earnings (loss) attributable to equity holders
$
89,382
$
(102,577)
Weighted average common shares outstanding
405,494
397,631
Basic earnings (loss) per common share
$
0.22
$
(0.26)
Diluted earnings (loss) per share computation
Net earnings (loss) attributable to equity holders
$
89,382
$
(102,577)
Weighted average common shares outstanding
405,494
397,631
Dilutive effect of stock options
1,641
-
Weighted average common shares outstanding, assuming dilution
407,135
397,631
Diluted earnings (loss) per common share
$
0.22
$
(0.26)
In 2022, there were
no
options excluded from the diluted weighted average number of common shares because their inclusion
would have been anti-dilutive (2021 -
1,802
).
46
24.
Supplemental cash flow information
Other operating items included in the statements of cash flows are as follows:
2022
2021
Changes in non-cash working capital:
Accounts receivable
$
99,601
$
(75,678)
Inventories
(162,858)
300,307
Supplies and prepaid expenses
(63,500)
(5,908)
Accounts payable and accrued liabilities
16,401
91,757
Reclamation payments
(28,492)
(19,542)
Other
19,417
(3,683)
Total
$
(119,431)
$
287,253
The changes arising from financing activities were as follows:
Long-term
Interest
Lease
Dividends
Share
debt
payable
obligation
payable
capital
Total
Balance at January 1, 2022
$
996,250
$
3,558
$
4,872
$
-
$
1,903,357
$
2,908,037
Changes from financing cash flows:
Dividends paid
-
-
-
(51,895)
-
(51,895)
Interest paid
-
(38,531)
(325)
-
-
(38,856)
Lease principal payments
-
-
(2,908)
-
-
(2,908)
Shares issued, stock option plan
-
-
-
-
9,632
9,632
Issuance of shares [note 17]
-
-
-
-
953,285
953,285
Total cash changes
-
(38,531)
(3,233)
(51,895)
962,917
869,258
Non-cash changes:
Amortization of issue costs
750
-
-
-
-
750
Dividends declared
-
-
-
51,895
-
51,895
Interest expense
-
38,984
325
-
-
39,309
Right-of-use asset additions
-
-
7,853
-
-
7,853
Other
-
-
(523)
-
-
(523)
Shares issued, stock option plan
-
-
-
-
2,469
2,469
Issuance of shares, deferred tax [note 17]
-
-
-
-
11,593
11,593
Foreign exchange
-
-
(7)
-
-
(7)
Total non-cash changes
750
38,984
7,648
51,895
14,062
113,339
Balance at December 31, 2022
$
997,000
$
4,011
$
9,287
$
-
$
2,880,336
$
3,890,634
25.
Share-based compensation plans
The Company has the following plans:
A.
Stock option plan
The Company has established a stock option plan under which options to purchase common shares may be granted to
employees of Cameco. Options granted under the stock option plan have an exercise price of not less than the closing price
quoted on the Toronto
Stock Exchange (TSX) for the common shares of Cameco on the trading day prior to the date on which
the option is granted. The options carry vesting periods of
one
to
three years
, and expire
eight years
from the date granted.
47
The aggregate number of common shares that may be issued pursuant to the Cameco stock option plan shall not exceed
43,017,198
of which
30,538,777
shares have been issued.
Stock option transactions for the respective years were as follows:
(Number of options)
2022
2021
Beginning of year
3,458,001
6,158,539
Options granted
-
-
Options forfeited
-
(18,005)
Options expired
(2,475)
(886,009)
Options exercised [note 17]
(401,955)
(1,796,524)
End of year
3,053,571
3,458,001
Exercisable
3,053,571
3,162,415
Weighted average share prices were as follows:
2022
2021
Beginning of year
$16.72
$16.98
Options granted
-
-
Options forfeited
-
26.08
Options expired
26.81
22.05
Options exercised
23.96
14.90
End of year
$15.75
$16.72
Exercisable
$15.75
$16.85
The weighted average share price at the dates of exercise during 2022 was $
23.96
per share (2021 - $
22.09
).
Total
options outstanding and exercisable at December 31, 2022 were as follows:
Options outstanding
Options exercisable
Option price per share
Number
Weighted
average
remaining
life
Weighted
average
exercisable
price
Number
Weighted
average
exercisable
price
$
11.32
-
15.83
1,772,271
3.2
$14.57
1,772,271
$14.57
$
15.84
-
19.3
1,281,300
0.8
$17.39
1,281,300
$17.39
3,053,571
3,053,571
The foregoing options have expiry dates ranging from March 1, 2023 to February 28, 2027.
48
B.
Executive performance share unit (PSU)
The Company has established a PSU plan whereby it provides each plan participant an annual grant of PSUs in an amount
determined by the board. Each PSU represents one phantom common share that entitles the participant to a payment of one
Cameco common share purchased on the open market, or cash with an equivalent market value, at the participant’s discretion
provided they have met their ownership requirements, at the end of each three-year period if certain performance and vesting
criteria have been met. The final value of the PSUs will be based on the value of Cameco common shares at the end of the
three-year period and the number of PSUs that ultimately vest. During the vesting period, dividend equivalents accrue to the
participants in the form of additional share units as of each normal cash dividend payment date of Cameco’s common shares.
Vesting of PSUs at the end of the three-year period is based on Cameco’s ability to meet its annual operating targets and
whether the participating executive remains employed by Cameco at the end of the
three-year
vesting period
. If the participant
elects a cash payout, the redemption amount will be based on the volume-weighted average trading price of Cameco’s
common shares on March 1 or, if March 1 is not a trading day,
on the first trading day following March 1. As of December 31,
2022, the total number of PSUs held by the participants, after adjusting for forfeitures on retirement, was
1,255,255
(2021 -
1,495,709
).
C.
Restricted share unit (RSU)
The Company has established an RSU plan whereby it provides each plan participant an annual grant of RSUs in an amount
determined by the board. Each RSU represents one phantom common share that entitles the participant to a payment of one
Cameco common share purchased on the open market, or cash with an equivalent market value, at the board’s discretion.
The RSUs carry vesting periods of
one
to three years
, and the final value of the units will be based on the value of Cameco
common shares at the end of the vesting periods. In addition, certain eligible participants have a single vesting date on the
third anniversary of the date of the grant. These same participants, if they have met or are not subject to share ownership
requirements, may elect to have their award paid as a lump sum cash amount. During the vesting period, dividend equivalents
accrue to the participants in the form of additional share units as of each normal cash dividend payment date of Cameco’s
common shares. As of December 31, 2022, the total number of RSUs held by the participants was
1,131,493
(2021 -
1,081,783
).
D.
Phantom stock option
The Company has established a phantom stock option plan for eligible non-North American employees. Employees receive
the equivalent value of shares in cash when exercised. Options granted under the phantom stock option plan have an award
value equal to the closing price quoted on the TSX for the common shares of Cameco on the trading day prior to the date on
which the option is granted. The options
vest over three years and expire eight years from the date granted
. As of
December 31, 2022, the number of options held by participating employees was
94,135
(2021 -
173,835
) with exercise prices
ranging from $
11.32
to $
19.30
per share (2021 - $
11.32
to $
26.81
) and a weighted average exercise price of $
12.55
(2021 -
$
13.88
).
E.
Phantom restricted share unit (PRSU)
The Company has established a PRSU plan whereby it provides non-North American employees an annual grant of PRSUs in
an amount determined by the board. Each PRSU represents one phantom common share that entitles the participant to a
payment of cash with an equivalent market value.
The PRSUs carry vesting periods of
one
to three years
, and the final value
of the units will be based on the value of Cameco common shares at the end of the vesting periods. In addition, certain eligible
participants have a single vesting date on the third anniversary of the date of the grant. During the vesting period, dividend
equivalents accrue to the participants in the form of additional share units as of each normal cash dividend payment date of
Cameco’s common shares. As of December 31, 2022, the total number of PRSUs held by the participants was
21,148
(2021 -
16,027
).
49
F.
Employee share ownership plan
Cameco also has an employee share ownership plan, whereby both employee and Company contributions are used to
purchase shares on the open market for employees. The Company’s contributions are expensed during the year of
contribution.
Under the plan, employees have the opportunity to participate in the program to a maximum of 6% of eligible
earnings each year with Cameco matching the first 3% of employee-paid shares by 50%. Cameco contributes $1,000 of
shares annually to each employee that is enrolled in the plan
.
Shares purchased with Company contributions and with
dividends paid on such shares become unrestricted 12 months from the date on which such shares were purchased
. At
December 31, 2022, there were
2,603
participants in the plan (2021 -
2,301
). The total number of shares purchased in 2022
with Company contributions was
116,530
(2021 -
149,822
). In 2022, the Company’s contributions totaled $
3,541,000
(2021 -
$
3,301,000
).
G.
Deferred share unit (DSU)
Cameco offers a DSU plan to non-employee directors. A DSU is a notional unit that reflects the market value of a single
common share of Cameco.
60% of each director’s annual retainer is paid in DSUs. In addition, on an annual basis, directors
can elect to receive 25%, 50%, 75% or 100% of the remaining 40% of their annual retainer and any additional fees in the form
of DSUs
. If a director meets their ownership requirements, the director may elect to take 25%, 50%, 75% or 100% of their
annual retainer and any fees in cash, with the balance, if any, to be paid in DSUs.
Each DSU fully vests upon award
. Dividend
equivalents accrue to the participants in the form of additional share units as of each normal cash dividend payment date of
Cameco’s common shares. The DSUs will be redeemed for cash upon a director leaving the board. The redemption amount
will be based upon the weighted average of the closing prices of the common shares of Cameco on the TSX for the last 20
trading days prior to the redemption date multiplied by the number of DSUs held by the director. As of December 31, 2022, the
total number of DSUs held by participating directors was
547,304
(2021 -
579,362
).
Equity-settled plans
Cameco records compensation expense under its equity-settled plans with an offsetting credit to contributed surplus, to reflect
the estimated fair value of units granted to employees. During the year, the Company recognized the following expenses
under these plans:
2022
2021
Employee share ownership plan
$
3,541
$
3,301
Restricted share unit plan
3,273
2,933
Performance share unit plan
(a)
-
1,237
Stock option plan
45
366
Total
$
6,859
$
7,837
(a)
There are
no
remaining PSUs whereby it is at the board’s discretion whether shares will be purchased on the open market
or redeemed for cash with an equivalent market value.
Fair value measurement of equity-settled plans
The fair value of RSUs granted was determined based on their intrinsic value on the date of grant. Expected volatility was
estimated by considering historic average share price volatility.
50
The inputs used in the measurement of the fair values at grant date of the equity-settled RSU plan were as follows:
Grant date
Mar 1/22
Number of options granted
129,910
Average strike price
$31.17
Expected forfeitures
10%
Weighted average grant date fair values
$31.17
Cash-settled plans
Cameco has recognized the following expenses under its cash-settled plans:
2022
2021
Performance share unit plan
$
11,221
$
25,784
Restricted share unit plan
9,342
6,890
Deferred share unit plan
2,811
6,741
Phantom stock option plan
751
2,261
Phantom restricted share unit plan
244
163
Total
$
24,369
$
41,839
At December 31, 2022, a liability of $
59,577,000
(2021 - $
61,030,000
) was included in the consolidated statement of financial
position to recognize accrued but unpaid expenses for cash-settled plans.
Fair value measurement of cash-settled plans
The fair value of the units granted through the PSU plan was determined based on Monte Carlo simulation and projections of
the non-market criteria. The fair value of RSUs and PRSUs granted was determined based on their intrinsic value on the date
of grant. The phantom stock option plan was measured based on the Black-Scholes option-pricing model. Expected volatility is
estimated by considering historic average share price volatility.
The inputs used in the measurement of the fair values of the cash-settled share-based payment plans at the March 1, 2022
grant date were as follows:
Phantom
PSU
RSU
RSU
Number of units
238,610
159,140
10,142
Expected vesting
92%
-
-
Expected dividend
-
-
$0.08
Expected life of option
3
years
3
years
3
years
Expected forfeitures
9%
9%
7%
Weighted average measurement date fair values
$31.17
$31.17
$31.17
51
The inputs used in the measurement of the fair values of the cash-settled share-based payment plans at the reporting date
were as follows:
Phantom
Phantom
stock options
PSU
RSU
RSU
Number of units
94,135
1,255,255
815,098
21,148
Expected vesting
-
72%
-
-
Average strike price
$12.55
-
-
-
Expected dividend
$0.12
-
-
$0.12
Expected volatility
53%
-
-
-
Risk-free interest rate
3.8%
-
-
-
Expected life of option
3
years
0.7
years
0.8
years
1.4
years
Expected forfeitures
7%
2%
8%
8%
Weighted average measurement date fair values
$20.22
$30.69
$30.69
$30.69
In addition to these inputs, other features of the PSU grant were incorporated into the measurement of fair value. The non-
market criteria relating to realized selling prices and operating targets have been incorporated into the valuation at both grant
and reporting date by reviewing prior history and corporate budgets.
26.
Pension and other post-retirement benefits
Cameco maintains both defined benefit and defined contribution plans providing pension benefits to substantially all of its
employees. All regular and temporary employees participate in a registered defined contribution plan. This plan is registered
under the Pension Benefits Standard Act, 1985. In addition, all Canadian-based executives participate in a non-registered
supplemental executive pension plan which is a defined benefit plan.
Under the supplemental executive pension plan (SEPP), Cameco provides a lump sum benefit equal to the present value of a
lifetime pension benefit based on the executive’s length of service and final average earnings. The plan provides for
unreduced benefits to be paid at the normal retirement age of 65, however unreduced benefits could be paid if the executive
was at least 60 years of age and had 20 years of service at retirement. This program provides for a benefit determined by a
formula based on earnings and service, reduced by the benefits payable under the registered base plan. Security is provided
for the SEPP benefits through a letter of credit held by the plan’s trustee. The face amount of the letter of credit is determined
each year based on the wind-up liabilities of the supplemental plan, less any plan assets currently held with the trustee. A
valuation is required annually to determine the letter of credit amount. Benefits will continue to be paid from plan assets until
the fund is exhausted, at which time Cameco will begin paying benefits from corporate assets.
Cameco also maintains non-pension post-retirement plans (“other benefit plans”) which are defined benefit plans that cover
such benefits as group life insurance and supplemental health and dental coverage to eligible employees and their
dependents. The costs related to these plans are charged to earnings in the period during which the employment services are
rendered. These plans are funded by Cameco as benefit claims are made.
The board of directors of Cameco has final responsibility and accountability for the Cameco retirement programs. The board is
ultimately responsible for managing the programs to comply with applicable legislation, providing oversight over the general
functions and setting certain policies.
Cameco expects to pay $
1,675,000
in contributions and letter of credit fees to its defined benefit plans in 2023.
The post-retirement plans expose Cameco to actuarial risks, such as longevity risk, market risk, interest rate risk, liquidity risk
and foreign currency risk. The other benefit plans expose Cameco to risks of higher supplemental health and dental utilization
than expected. However, the other benefit plans have limits on Cameco’s annual benefits payable.
The effective date of the most recent valuation for funding purposes on the registered defined benefit pension plans is
January 1, 2021. The next planned effective date for valuations is January 1, 2024.
52
Cameco has more than one defined benefit plan and has generally provided aggregated disclosures in respect of these plans,
on the basis that these plans are not exposed to materially different risks. Information relating to Cameco’s defined benefit
plans is shown in the following table:
Pension benefit plans
Other benefit plans
2022
2021
2022
2021
Fair value of plan assets, beginning of year
$
5,693
$
6,217
$
-
$
-
Interest income on plan assets
157
144
-
-
Return on assets excluding interest income
(555)
172
-
-
Employer contributions
-
67
-
-
Benefits paid
(890)
(903)
-
-
Administrative costs paid
(3)
(4)
-
-
Fair value of plan assets, end of year
$
4,402
$
5,693
$
-
$
-
Defined benefit obligation, beginning of year
$
69,998
$
72,119
$
24,697
$
25,827
Current service cost
2,302
2,332
915
956
Interest cost
1,867
1,550
726
652
Actuarial loss (gain) arising from:
- financial assumptions
(20,913)
(1,996)
(5,881)
(1,403)
- experience adjustment
1,396
(903)
161
(697)
Benefits paid
(3,666)
(1,741)
(1,254)
(638)
Foreign exchange
234
(1,363)
-
-
Defined benefit obligation, end of year
$
51,218
$
69,998
$
19,364
$
24,697
Defined benefit liability [note 15]
$
(46,816)
$
(64,305)
$
(19,364)
$
(24,697)
The percentages of the total fair value of assets in the pension plans for each asset category at December 31 were as follows:
Pension benefit plans
2022
2021
Asset category
(a)
Canadian equity securities
6%
8%
U.S. equity securities
11%
13%
Global equity securities
6%
8%
Canadian fixed income
28%
32%
Other
(b)
49%
39%
Total
100%
100%
(a) The defined benefit plan assets contain
no
material amounts of related party assets at December 31, 2022 and 2021
respectively.
(b) Relates mainly to the value of the refundable tax account held by the Canada Revenue Agency. The refundable total is
approximately
equal to half of the sum of the realized investment income plus employer contributions less half of the benefits
paid by the plan
.
53
The following represents the components of net pension and other benefit expense included primarily as part of administration.
Pension benefit plans
Other benefit plans
2022
2021
2022
2021
Current service cost
$
2,302
$
2,332
$
915
$
956
Net interest cost
1,710
1,406
726
652
Administration cost
3
4
-
-
Defined benefit expense [note 19]
4,015
3,742
1,641
1,608
Defined contribution pension expense [note 19]
15,189
12,939
-
-
Net pension and other benefit expense
$
19,204
$
16,681
$
1,641
$
1,608
The total amount of actuarial gains recognized in other comprehensive income is:
Pension benefit plans
Other benefit plans
2022
2021
2022
2021
Actuarial gains
$
(19,517)
$
(2,899)
$
(5,720)
$
(2,100)
Return on plan assets excluding
interest income
555
(172)
-
-
$
(18,962)
$
(3,071)
$
(5,720)
$
(2,100)
The assumptions used to determine the Company’s defined benefit obligation and net pension and other benefit expense
were as follows at December 31 (expressed as weighted averages):
Pension benefit plans
Other benefit plans
2022
2021
2022
2021
Discount rate - obligation
4.5%
2.3%
5.1%
2.9%
Discount rate - expense
2.3%
2.4%
2.9%
2.5%
Rate of compensation increase
3.0%
3.0%
-
-
Health care cost trend rate
-
-
5.0%
5.0%
Dental care cost trend rate
-
-
4.5%
4.5%
At December 31, 2022, the weighted average duration of the defined benefit obligation for the pension plans was
17.1
years
(2021 -
20.0
years) and for the other benefit plans was
11.3
years (2021 -
13.6
years).
A
1
% change at the reporting date to one of the relevant actuarial assumptions, holding other assumptions
constant, would have affected the defined benefit obligation by the following:
Pension benefit plans
Other benefit plans
Increase
Decrease
Increase
Decrease
Discount rate
$
(6,148)
$
7,737
$
(2,366)
$
2,975
A 1% change in any of the other assumptions would not have a significant impact on the defined benefit obligation.
The methods and assumptions used in preparing the sensitivity analyses are the same as the methods and assumptions used
in determining the financial position of Cameco’s plans as at December 31, 2022. The sensitivity analyses are determined by
varying the sensitivity assumption and leaving all other assumptions unchanged. Therefore, the sensitivity analyses do not
recognize any interdependence in the assumptions. The methods and assumptions used in determining the above sensitivity
are consistent with the methods and assumptions used in the previous year.
54
In addition, an increase of one year in the expected lifetime of plan participants in the pension benefit plans would increase the
defined benefit obligation by $
1,236,000
.
To
measure the longevity risk for these plans, the mortality rates were reduced such that the average life expectancy for all
members increased by one year. The reduced mortality rates were subsequently used to re-measure the defined benefit
obligation of the entire plan.
27.
Financial instruments and related risk management
Cameco is exposed in varying degrees to a variety of risks from its use of financial instruments. Management and the board of
directors, both separately and together, discuss the principal risks of our businesses. The board sets policies for the
implementation of systems to manage, monitor and mitigate identifiable risks. Cameco’s risk management objective in relation
to these instruments is to protect and minimize volatility in cash flow. The types of risks Cameco is exposed to, the source of
risk exposure and how each is managed is outlined below.
Market risk
Market risk is the risk that changes in market prices, such as commodity prices, foreign currency exchange rates and interest
rates, will affect the Company’s earnings or the fair value of its financial instruments. Cameco engages in various business
activities which expose the Company to market risk. As part of its overall risk management strategy, Cameco uses derivatives
to manage some of its exposures to market risk that result from these activities.
Derivative instruments may include financial and physical forward contracts. Such contracts may be used to establish a fixed
price for a commodity, an interest-bearing obligation or a cash flow denominated in a foreign currency.
Market risks are
monitored regularly against defined risk limits and tolerances.
Cameco’s actual exposure to these market risks is constantly changing as the Company’s portfolios of foreign currency and
interest rate contracts change.
The types of market risk exposure and the way in which such exposure is managed are as follows:
A.
Commodity price risk
As a significant producer and supplier of uranium and nuclear fuel processing services, Cameco bears significant exposure to
changes in prices for these products. A substantial change in prices will affect the Company’s net earnings and operating cash
flows. Prices for Cameco’s products are volatile and are influenced by numerous factors beyond the Company’s control, such
as supply and demand fundamentals and geopolitical events.
Cameco’s sales contracting strategy focuses on reducing the volatility in future earnings and cash flow, while providing both
protection against decreases in market price and retention of exposure to future market price increases. To mitigate the risks
associated with the fluctuations in the market price for uranium products, Cameco seeks to maintain a portfolio of uranium
product sales contracts with a variety of delivery dates and pricing mechanisms that provide a degree of protection from
pricing volatility.
B.
Foreign exchange risk
The relationship between the Canadian and US dollar affects financial results of the uranium business as well as the fuel
services business. Sales of uranium product, conversion and fuel manufacturing services are routinely denominated in US
dollars while production costs are largely denominated in Canadian dollars.
55
Cameco attempts to provide some protection against exchange rate fluctuations by planned hedging activity designed to
smooth volatility. To
mitigate risks associated with foreign currency, Cameco enters into forward sales and option contracts to
establish a price for future delivery of the foreign currency. These foreign currency contracts are not designated as hedges and
are recorded at fair value with changes in fair value recognized in earnings. Cameco also has a natural hedge against US
currency fluctuations because a portion of its annual cash outlays, including purchases of uranium and conversion services, is
denominated in US dollars.
Cameco holds a number of financial instruments denominated in foreign currencies that expose the Company to foreign
exchange risk. Cameco measures its exposure to foreign exchange risk on financial instruments as the change in carrying
values that would occur as a result of reasonably possible changes in foreign exchange rates, holding all other variables
constant. As of the reporting date, the Company has determined its pre-tax exposure to foreign currency exchange risk on
financial instruments to be as follows based on a
5
% weakening of the Canadian dollar:
Carrying value
Currency
(Cdn)
Gain (loss)
Cash and cash equivalents
USD
$
414,683
$
20,734
Short-term investments
USD
886,020
44,301
Accounts receivable
USD
136,246
6,812
Accounts payable and accrued liabilities
USD
(176,746)
(8,837)
Net foreign currency derivatives
USD
(48,251)
(71,836)
A
5
% strengthening of the Canadian dollar against the currencies above at December 31, 2022 would have had an equal but
opposite effect on the amounts shown above, assuming all other variables remained constant.
C.
Interest rate risk
The Company has a strategy of minimizing its exposure to interest rate risk by maintaining target levels of fixed and variable
rate borrowings. The proportions of outstanding debt carrying fixed and variable interest rates are reviewed by senior
management to ensure that these levels are within approved policy limits. At December 31, 2022, the proportion of Cameco’s
outstanding debt that carries fixed interest rates is
92
% (2021 -
92
%).
Cameco was exposed to interest rate risk during the year through its interest rate swap contracts whereby fixed rate payments
on a notional amount of $
75,000,000
of the Series H senior unsecured debentures were swapped for variable rate payments.
Under the terms of the swap, Cameco makes interest payments based on
the three-month Canada Dealer Offered Rate
plus
an average margin of
1.3
% and receives fixed interest payments of
2.95
%. At December 31, 2022, the fair value of Cameco’s
interest rate swap net liability was $
7,284,000
(2021 - $
673,000
).
Cameco measures its exposure to interest rate risk as the change in cash flows that would occur as a result of reasonably
possible changes in interest rates, holding all other variables constant. As of the reporting date, the Company has determined
the impact on earnings of a
1
% increase in interest rate on its interest rate contracts to be a loss of $
766,000
.
56
Counterparty credit risk
Counterparty credit risk is associated with the ability of counterparties to satisfy their contractual obligations to Cameco,
including both payment and performance. The maximum exposure to credit risk, as represented by the carrying amount of the
financial assets, at December 31 was:
2022
2021
Cash and cash equivalents
$
1,143,674
$
1,247,447
Short-term investments
1,138,174
84,906
Accounts receivable [note 7]
178,088
272,220
Derivative assets [note 11]
2,807
32,098
Cash and cash equivalents
Cameco held cash and cash equivalents of $
1,143,674,000
at December 31, 2022 (2021 - $
1,247,447,000
). Cameco
mitigates its credit risk by ensuring that balances are held with counterparties with high credit ratings. The Company monitors
the credit rating of its counterparties on a monthly basis and has controls in place to ensure prescribed exposure limits with
each counterparty are adhered to.
Impairment on cash and cash equivalents has been measured on a 12-month ECL basis and reflects the short maturities of
the exposures. The Company considers that its cash and cash equivalents have low credit risk based on the external credit
ratings of the counterparties. Cameco has assessed its counterparty credit risk on cash and cash equivalents by applying
historic global default rates to outstanding cash balances based on S&P rating. The conclusion of this assessment is that the
loss allowance is insignificant.
Short-term investments
Cameco held short-term investments of $
1,138,174,000
at December 31, 2022 (2021 - $
84,906,000
). The Company mitigates
its credit risk by requiring that the issuer/guarantor of the investment have a minimum short-term credit rating and/or a long-
term debt rating at the time of purchase, according to the investment credit ratings as issued by DBRS or S&P,
or the
equivalent of the DBRS or S&P rating at another reputable rating agency.
In addition to the credit-rating requirement, Cameco also mitigates risk by prescribing limits by counterparty and types of
investment products.
Cameco has assessed its counterparty credit risk related to short-term investments by applying historic default rates to
outstanding investment balances based on S&P rating. The conclusion of this assessment is that the loss allowance is
insignificant.
Accounts receivable
Cameco’s sales of uranium product, conversion and fuel manufacturing services expose the Company to the risk of non-
payment. Cameco manages the risk of non-payment by monitoring the credit-worthiness of its customers and seeking pre-
payment or other forms of payment security
from customers with an unacceptable level of credit risk.
57
A summary of the Company’s exposure to credit risk for trade receivables is as follows:
Carrying
value
Investment grade credit rating
$
139,708
Non-investment grade credit rating
27,980
Total gross carrying amount
$
167,688
Loss allowance
-
Net
$
167,688
At December 31, 2022, there were no significant concentrations of credit risk and no amounts were held as collateral.
Historically, Cameco has experienced minimal customer defaults and, as a result, considers the credit quality of its accounts
receivable to be high.
Cameco uses customer credit rating data, historic default rates and aged receivable analysis to measure the ECLs of trade
receivables from corporate customers, which comprise a small number of large balances. Since the Company has not
experienced customer defaults in the past, applying historic default rates in calculating ECLs, as well as considering forward-
looking information, resulted in an insignificant allowance for losses.
The following table provides information about Cameco’s aged trade receivables as at December 31, 2022:
Corporate
Other
customers
customers
Total
Current (not past due)
$
166,361
$
398
166,759
1-30 days past due
639
171
810
More than 30 days past due
99
20
119
Total
$
167,099
$
589
167,688
Liquidity risk
Financial liquidity represents Cameco’s ability to fund future operating activities and investments. Cameco ensures that there
is sufficient capital in order to meet short-term business requirements, after taking into account cash flows from operations and
the Company’s holdings of cash and cash equivalents. The Company believes that these sources will be sufficient to cover the
likely short-term and long-term cash requirements.
The table below outlines the Company’s available debt facilities at December 31, 2022:
Outstanding and
Total amount
committed
Amount available
Unsecured revolving credit facility [note 14]
$
1,000,000
$
-
$
1,000,000
Letter of credit facilities [note 14]
1,756,754
1,593,379
163,375
58
The tables below present a maturity analysis of Cameco’s financial liabilities, including principal and interest, based on the
expected cash flows from the reporting date to the contractual maturity date:
Due in
Carrying
Contractual
less than
Due in 1-3
Due in 3-5
Due after 5
amount
cash flows
1 year
years
years
years
Accounts payable and accrued liabilities
$
374,714
$
374,714
$
374,714
$
-
$
-
$
-
Long-term debt
997,000
1,000,000
-
500,000
400,000
100,000
Foreign currency contracts
51,058
51,058
23,476
27,582
-
-
Interest rate contracts
7,284
7,284
2,437
2,987
1,860
-
Lease obligation [note 15]
9,287
10,314
2,681
2,595
1,718
3,320
Total contractual repayments
$
1,439,343
$
1,443,370
$
403,308
$
533,164
$
403,578
$
103,320
Due in
less than
Due in 1-3
Due in 3-5
Due after 5
Total
1 year
years
years
years
Total interest payments on long-term debt
$
192,225
$
37,840
$
44,255
$
33,780
$
76,350
Measurement of fair values
A.
Accounting classifications and fair values
The following tables summarize the carrying amounts and accounting classifications of Cameco’s financial instruments at the
reporting date:
At December 31, 2022
FVTPL
Amortized
cost
Total
Financial assets
Cash and cash equivalents
$
-
$
1,143,674
$
1,143,674
Short-term investments
-
1,138,174
1,138,174
Accounts receivable [note 7]
-
183,944
183,944
Derivative assets [note 11]
Foreign currency contracts
2,807
-
2,807
$
2,807
$
2,465,792
$
2,468,599
Financial liabilities
Accounts payable and accrued liabilities [note 13]
$
-
$
374,714
$
374,714
Lease obligation [note 15]
-
9,287
9,287
Derivative liabilities [note 15]
Foreign currency contracts
51,058
-
51,058
Interest rate contracts
7,284
-
7,284
Long-term debt [note 14]
-
997,000
997,000
58,342
1,381,001
1,439,343
Net
$
(55,535)
$
1,084,791
$
1,029,256
59
At December 31, 2021
FVTPL
Amortized
cost
Total
Financial assets
Cash and cash equivalents
$
-
$
1,247,447
$
1,247,447
Short-term investments
-
84,906
84,906
Accounts receivable [note 7]
-
276,139
276,139
Derivative assets [note 11]
Foreign currency contracts
31,534
-
31,534
Interest rate contracts
564
-
564
$
32,098
$
1,608,492
$
1,640,590
Financial liabilities
Accounts payable and accrued liabilities [note 13]
$
-
$
340,458
$
340,458
Lease obligation [note 15]
-
4,872
4,872
Derivative liabilities [note 15]
Foreign currency contracts
3,760
-
3,760
Interest rate contracts
1,237
-
1,237
Long-term debt [note 14]
-
996,250
996,250
4,997
1,341,580
1,346,577
Net
$
27,101
$
266,912
$
294,013
Cameco has pledged $
239,000,000
of cash as security against certain of its letter of credit facilities. This cash is being used
as collateral for an interest rate reduction on the letter of credit facilities. The collateral account has a term of
five years
effective July 1, 2018. Cameco retains full access to this cash.
Cameco has issued guarantees to certain banks in respect of the credit facilities granted to various subsidiaries. These
facilities consist of daily overdraft limits and credit lines. At December 31, 2022 the Company has issued guarantees of up to
$
179,700,000
($
132,600,000
(US)), which is the maximum amount the Company could be exposed to at any point in time.
During 2021, Cameco divested of its investments in equity securities. The fair value at the date of derecognition and the
cumulative gain or loss on disposal for the year ended December 31, 2021 were as follows:
Fair Value
Gain (loss)
Investment in Denison Mines Corp.
$
34,827
$
15,257
Investment in UEX Corporation
19,605
8,758
Investment in ISO Energy Ltd.
10,756
8,078
Investment in GoviEx
3,558
2,996
Other
265
(750)
$
69,011
$
34,339
The gains were presented net of tax. Cameco elected to transfer these cumulative net gains from equity investments at FVOCI
to retained earnings in the statement of changes in equity.
Cameco has not irrevocably designated a financial asset that would otherwise meet the requirements to be measured at
amortized cost at FVOCI or FVTPL to eliminate or significantly reduce an accounting mismatch that would otherwise arise.
60
The following tables summarize the carrying amounts and level 2 fair value measurements of Cameco’s financial instruments:
As at December 31, 2022
Carrying value
Fair value
Derivative assets [note 11]
Foreign currency contracts
$
2,807
$
2,807
Derivative liabilities [note 15]
Foreign currency contracts
(51,058)
(51,058)
Interest rate contracts
(7,284)
(7,284)
Long-term debt [note 14]
(997,000)
(1,014,010)
Net
$
(1,052,535)
$
(1,069,545)
As at December 31, 2021
Carrying value
Fair value
Derivative assets [note 11]
Foreign currency contracts
$
31,534
$
31,534
Interest rate contracts
564
564
Derivative liabilities [note 15]
Foreign currency contracts
(3,760)
(3,760)
Interest rate contracts
(1,237)
(1,237)
Long-term debt [note 14]
(996,250)
(1,103,978)
Net
$
(969,149)
$
(1,076,877)
The preceding tables exclude fair value information for financial instruments whose carrying amounts are a reasonable
approximation of fair value. The carrying values of Cameco’s cash and cash equivalents, short-term investments, accounts
receivable, and accounts payable and accrued liabilities approximate their fair values as a result of the short-term nature of the
instruments.
There were no transfers between level 1 and level 2 during the period. Cameco does not have any financial instruments that
are classified as level 3 as of the reporting date.
B.
Financial instruments measured at fair value
Cameco measures its derivative financial instruments and long-term debt at fair value. Derivative financial instruments and
long-term debt are classified as a recurring level 2 fair value measurement.
The fair value of Cameco’s long-term debt is determined using quoted market yields as of the reporting date, which ranged
from
3.3
% to
4.2
% (2021 -
1.1
% to
1.7
%).
Foreign currency derivatives consist of foreign currency forward contracts, options and swaps. The fair value of foreign
currency options is measured based on the Black Scholes option-pricing model. The fair value of foreign currency forward
contracts and swaps is measured using a market approach, based on the difference between contracted foreign exchange
rates and quoted forward exchange rates as of the reporting date.
Interest rate derivatives consist of interest rate swap contracts. The fair value of interest rate swaps is determined by
discounting expected future cash flows from the contracts. The future cash flows are determined by measuring the difference
between fixed interest payments to be received and floating interest payments to be made to the counterparty based on
Canada Dealer Offer Rate forward interest rate curves.
61
Where applicable, the fair value of the derivatives reflects the credit risk of the instrument and includes adjustments to take
into account the credit risk of the Company and counterparty. These adjustments are based on credit ratings and yield curves
observed in active markets at the reporting date.
Derivatives
The following table summarizes the fair value of derivatives and classification on the consolidated statements of financial
position:
2022
2021
Non-hedge derivatives:
Foreign currency contracts
$
(48,251)
$
27,774
Interest rate contracts
(7,284)
(673)
Net
$
(55,535)
$
27,101
Classification:
Current portion of long-term receivables, investments and other [note 11]
$
1,331
$
22,652
Long-term receivables, investments and other [note 11]
1,476
9,446
Current portion of other liabilities [note 15]
(25,913)
(378)
Other liabilities [note 15]
(32,429)
(4,619)
Net
$
(55,535)
$
27,101
The following table summarizes the different components of the gains (losses) on derivatives included in net earnings:
2022
2021
Non-hedge derivatives:
Foreign currency contracts
$
(66,360)
$
13,202
Interest rate contracts
(6,589)
(673)
Net
$
(72,949)
$
12,529
28.
Capital management
Cameco’s management considers its capital structure to consist of bank overdrafts, long-term debt, short-term debt (net of
cash and cash equivalents and short-term investments), non-controlling interest and shareholders’ equity.
Despite the impacts of COVID-19 on the global economy, Cameco’s approach to capital management has remained
consistent. Cameco’s capital structure reflects its strategy and the environment in which it operates. Delivering returns to long-
term shareholders is a top priority. The Company’s objective is to maximize cash flow while maintaining its investment grade
rating through close capital management of our balance sheet metrics. Capital resources are managed to allow it to support
achievement of its goals while managing financial risks such as weakness in the market, litigation risk and refinancing risk.
The overall objectives for managing capital in 2022 reflect the environment that the Company is operating in, similar to the
prior comparative period.
62
The capital structure at December 31 was as follows:
2022
2021
Long-term debt [note 14]
997,000
996,250
Cash and cash equivalents
(1,143,674)
(1,247,447)
Short-term investments
(1,138,174)
(84,906)
Net debt
(1,284,848)
(336,103)
Non-controlling interest
11
127
Shareholders' equity
5,836,054
4,845,841
Total
equity
5,836,065
4,845,968
Total capital
$
4,551,217
$
4,509,865
Cameco is bound by certain covenants in its general credit facilities. These covenants place restrictions on total debt, including
guarantees and set minimum levels for net worth. As of December 31, 2022, Cameco met these requirements.
29.
Segmented information
Cameco has two reportable segments: uranium and fuel services. Cameco's reportable segments are strategic business units
with different products, processes and marketing strategies.
The uranium segment involves the exploration for, mining, milling,
purchase and sale of uranium concentrate. The fuel services segment involves the refining, conversion and fabrication of
uranium concentrate and the purchase and sale of conversion services.
Cost of sales in the uranium segment includes care and maintenance costs for our operations that have had production
suspensions as well as operational readiness costs for our operations that are resuming operations. Operational readiness
costs include costs to complete critical projects, perform maintenance readiness checks, and recruit and train sufficient mine
and mill personnel before beginning operations. Cameco expensed $
218,439,000
of care and maintenance and operational
readiness costs during the year (2021 - $
209,556,000
of care and maintenance costs). Included in this amount in 2021 is
$
40,359,000
relating to care and maintenance costs for operations suspended as a result of COVID-19 and the related impact
of increased purchasing activity at a higher cost than produced pounds. This had a negative impact on gross profit in the
uranium segment.
Accounting policies used in each segment are consistent with the policies outlined in the summary of significant accounting
policies.
63
A.
Business segments - 2022
For the year ended December 31, 2022
Uranium
Fuel
services
Other
Total
Revenue
$
1,480,146
$
365,063
$
22,794
$
1,868,003
Expenses
Cost of products and services sold
1,223,558
215,660
18,118
1,457,336
Depreciation and amortization
135,800
32,618
8,958
177,376
Cost of sales
1,359,358
248,278
27,076
1,634,712
Gross profit (loss)
120,788
116,785
(4,282)
233,291
Administration
-
-
172,029
172,029
Exploration
10,578
-
-
10,578
Research and development
-
-
12,175
12,175
Other operating expense (income)
25,845
(2,901)
-
22,944
(Gain) loss on disposal of assets
726
(212)
-
514
Finance costs
-
-
85,728
85,728
Loss on derivatives
-
-
72,949
72,949
Finance income
-
-
(37,499)
(37,499)
Share of earnings from equity-accounted investee
(93,988)
-
-
(93,988)
Other income
(22,802)
-
(74,132)
(96,934)
Earnings (loss) before income taxes
200,429
119,898
(235,532)
84,795
Income tax recovery
(4,469)
Net earnings
89,264
Capital expenditures for the year
$
101,547
$
39,736
$
2,198
$
143,481
64
For the year ended December 31, 2021
Uranium
Fuel
services
Other
Total
Revenue
$
1,054,993
$
404,277
$
15,714
$
1,474,984
Expenses
Cost of products and services sold
1,028,816
242,574
11,245
1,282,635
Depreciation and amortization
134,629
43,344
12,442
190,415
Cost of sales
1,163,445
285,918
23,687
1,473,050
Gross profit (loss)
(108,452)
118,359
(7,973)
1,934
Administration
-
-
127,566
127,566
Exploration
8,016
-
-
8,016
Research and development
-
-
7,168
7,168
Other operating income
(8,407)
-
-
(8,407)
(Gain) loss on disposal of assets
(2,886)
6,689
-
3,803
Finance costs
-
-
76,612
76,612
Gain on derivatives
-
-
(12,529)
(12,529)
Finance income
-
-
(6,804)
(6,804)
Share of earnings from equity-accounted investee
(68,283)
-
-
(68,283)
Other expense (income)
-
301
(21,654)
(21,353)
Earnings (loss) before income taxes
(36,892)
111,369
(178,332)
(103,855)
Income tax recovery
(1,201)
Net loss
(102,654)
Capital expenditures for the year
$
72,786
$
22,792
$
3,206
$
98,784
B.
Geographic segments
Revenue is attributed to the geographic location based on the location of the entity providing the services. The Company’s
revenue from external customers is as follows:
2022
2021
Canada
$
994,534
$
704,719
United States
873,469
770,265
$
1,868,003
$
1,474,984
The Company’s non-current assets, excluding deferred tax assets and financial instruments, by geographic location
are as follows:
2022
2021
Canada
$
3,042,533
$
3,100,285
Australia
397,678
395,223
United States
80,352
131,683
Kazakhstan
38
46
Germany
6
11
$
3,520,607
$
3,627,248
65
C.
Major customers
Cameco relies on a small number of customers to purchase a significant portion of its uranium concentrates and uranium
conversion services. During 2022, revenues from one customer of Cameco’s uranium and fuel services segments represented
approximately $
227,846,000
(2021 - $
166,068,000
), approximately
12
% (2021 -
11
%) of Cameco’s total revenues from these
segments.
As customers are relatively few in number, accounts receivable from any individual customer may periodically
exceed 10% of accounts receivable depending on delivery schedule.
30.
Group entities
The following are the principal subsidiaries and associates of the Company:
Principal place
Ownership interest
of business
2022
2021
Subsidiaries:
Cameco Fuel Manufacturing Inc.
Canada
100%
100%
Cameco Marketing Inc.
Canada
100%
100%
Cameco Inc.
US
100%
100%
Power Resources, Inc.
US
100%
100%
Crow Butte Resources, Inc.
US
100%
100%
Cameco Australia Pty. Ltd.
Australia
100%
100%
Cameco Europe Ltd.
Switzerland
100%
100%
Associates:
JV Inkai
Kazakhstan
40%
40%
31.
Joint operations
Cameco conducts a portion of its exploration, development, mining and milling activities through joint operations. Operations
are governed by agreements that provide for joint control of the strategic operating, investing and financing activities among
the partners. These agreements were considered in the determination of joint control. Cameco’s significant Canadian uranium
joint operation interests are McArthur River, Key Lake and Cigar Lake. The Canadian uranium joint operations allocate
uranium production to each joint operation participant and the joint operation participant derives revenue directly from the sale
of such product. Mining and milling expenses incurred by joint operations are included in the cost of inventory.
66
Cameco reflects its proportionate interest in these assets and liabilities as follows:
Principal place
of business
Ownership
2022
2021
Total assets
McArthur River
Canada
69.81%
$
998,368
$
1,010,956
Key Lake
Canada
83.33%
527,841
549,051
Cigar Lake
(a)
Canada
54.55%
1,219,036
1,294,333
$
2,745,245
$
2,854,340
Total liabilities
McArthur River
69.81%
$
37,881
$
36,697
Key Lake
83.33%
240,487
267,579
Cigar Lake
(a)
54.55%
50,362
45,503
$
328,730
$
349,779
(a) Cameco’s ownership stake in the Cigar Lake uranium mine in northern Saskatchewan was previously
50.025
%. On May
19, 2022, Cameco and Orano completed the acquisition of Idemitsu’s
7.875
% participating interest in the CLJV by acquiring
their pro rata shares through an asset purchase (note 6).
32.
Related parties
A.
Transactions with key management personnel
Key management personnel are those persons that have the authority and responsibility for planning, directing and controlling
the activities of the Company, directly or indirectly.
Key management personnel of the Company include executive officers,
vice-presidents, other senior managers and members of the board of directors.
In addition to their salaries, Cameco also provides non-cash benefits to executive officers and vice-presidents and contributes
to pension plans on their behalf (note 26). Senior management and directors also participate in the Company’s share-based
compensation plans (note 25).
Executive officers are subject to terms of notice ranging from three to six months. Upon resignation at the Company’s request,
they are entitled to termination benefits of up to the lesser of 18 to 24 months or the period remaining until age 65. The
termination benefits include gross salary plus the target short-term incentive bonus for the year in which termination occurs.
Compensation for key management personnel was comprised of:
2022
2021
Short-term employee benefits
$
23,557
$
20,663
Share-based compensation
(a)
21,149
34,639
Post-employment benefits
6,532
6,188
Termination
benefits
-
161
Total
$
51,238
$
61,651
(a) Excludes deferred share units held by directors (see note 25).
B.
Other related party transactions
Cameco purchases uranium concentrates from JV Inkai. For the year ended December 31, 2022, Cameco had purchases of
$
206,818,000
($
155,937,000
(US)) (2021 - $
233,621,000
($
185,763,000
(US))). Cameco received a cash dividend from JV
Inkai of $
117,698,000
($
92,425,000
(US)) (2021 - $
50,128,000
($
40,286,000
(US))).
67
33.
Commitments
On October 11, 2022, Cameco announced that it had entered into a strategic partnership with Brookfield Renewable Partners
(Brookfield Renewable) and its institutional partners to acquire Westinghouse Electric Company (Westinghouse), one of the
world’s largest nuclear services businesses. Brookfield Renewable, with its institutional partners, will own a
51
% interest in
Westinghouse and Cameco will own
49
%.
Cameco’s share of the purchase price will be funded with a combination of cash, debt and equity. The Company secured a
bridge loan facility of $
280,000,000
(US) as well as $
600,000,000
(US) in term loans. The bridge facility, if funded, will mature
364 days after the acquisition closing date and the term loans, which consist of
two
$
300,000,000
(US) tranches, are expected
to mature two and three years after the closing of the acquisition. In addition, as disclosed in note 17, Cameco issued
34,057,250
common shares pursuant to a public offering.
Transaction costs of $
41,227,000
have been included in supplies and prepaid expenses in the consolidated statement of
financial position as of the year ended December 31, 2022. Under the terms of the agreement, if the transaction does not
close, Cameco is entitled to recover a portion of these costs.